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  The main aim of this dissertation was to design and synthesize molecular probes with ease 
to be used in medical and environmental applications. The first chapter focuses on a novel pseudo-
rotaxane probe that can be used in 129Xe imaging, which was synthesized using commercially 
available cyclodextrin moieties with a one-step reaction. This is probe can be synthesized in high 
yields and results in an acceptable level of hyperCEST depletion percentage. The second chapter 
showcases pillararenes as a potential candidate for 129Xe imaging. In addition, this chapter discusses 
the aid of a computational programs to design the supramolecular scaffold before the synthesis. 
The third chapter is an extension of the first chapter, which focuses on designing rotaxanes probes, 
which are interlocked molecular structures. Furthermore, these novel cyclodextrin based rotaxanes 
were able to capture a positively charged guest which gives an access point to use these as a 
potential drug delivery agent. Chapter 4 describes on a novel supramolecular scaffold that is 
synthesized using a co-pillararene. This fluorescent co-pillararene is capable of switching from a 
self-inclusion form to an open form via temperature, solvent and external guests, which makes this 
pillararene an excellent molecular switch. Chapters 5 and 6 elaborate the use of water-soluble 
pillararene structures in toxicant removal via host-guest inclusion phenomena and self-aggregation 
with the use of commercially existing double-stranded DNA. Chapter 7 deviates from the 
supramolecular regime and discusses the development of novel antibiotic drug molecules and their 
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Hyperpolarized (HP) xenon-129 (Xe) mag- netic resonance (MR) imaging has the potential to 
detect biological analytes with high sensitivity and high resolution when coupled with xenon-
encapsulating molecular probes. Despite the development of numerous HP Xe probes, one of the 
challenges that has hampered the translation of these agents from in vitro demonstration to in vivo 
testing is the difficulty in synthesizing the Xe-encapsulating cage molecule. In this study, we 
demonstrate that a pseudorotaxane, based on a γ-cyclodextrin macrocycle, is easily synthesized in 






Hyperpolarized (HP) xenon-129 magnetic resonance imaging (MRI) has the potential to become a 
molecular imaging platform for safely producing highly resolved three-dimensional images of 
biochemical phenomena through the use of xenon- capturing molecular probes. Currently, the most 
prevalent molecular imaging techniques, positron emission tomography and single-photon 
emission computed tomography, involve the administration of radiolabeled chemical probes. Other 
methods for enhancing MR sensitivity, such as parahydrogen-induced polarization, signal 
amplification by reversible exchange, and dissolution dynamic nuclear polarization, and dynamic 
1H imaging techniques, such as paramagnetic chemical exchange saturation transfer, involve the 
difficult synthesis of molecular probes using parahydrogen, specific isotopes, or toxic metal ions 
before the imaging experiment is performed1-3. Contrastingly, molecular probes based on the 
pseudorotaxanes described herein are simple to synthesize and the inclusion of the nonradioactive, 
nontoxic 129Xe isotope occurs spontaneously in situ. Xe gas can be inhaled, and its biodistribution 
can be imaged using an MRI instrument with a broadband coil.4−6 HP Xe atoms cannot, by 
themselves, be tuned to target particular regions in the body, but targeted HP Xe biosensors that 
are capable of binding both biochemical receptors and xenon atoms in vivo have been postulated 
as a new molecular imaging platform.7−9  
Employing hyperpolarized nuclei and a saturation transfer pulse sequence, known as HyperCEST, 
provides up to a billion times sensitivity enhancement compared to that of thermally polarized 
nuclei, allowing for picomolar concentrations of the Xe-encapsulating probe to be detected.10-11 We 
recently disclosed the first in vivo images of an HP Xe probe in a live animal using the millimolar 
quantities of the nontargeted Xe cage, cucurbit[6]uril (CB6).12 This work demonstrated that 
molecular probes can be imaged in vivo via HyperCEST, but despite this work and numerous other 
prototypes,8,13−25 targeted HP Xe MRI biosensors have yet to be used for in vivo imaging in a whole 
animal. The development of these potential biosensors has not been slowed by a lack of interest in 
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the techniques or by barriers in MRI technology. In our opinion, the problem is more fundamental: 
the supramolecular hosts that encapsulate xenon are difficult to synthesize and functionalize, so 
sufficient quantities of the targeted probes for in vivo imaging are simply not available. Herein, we 
describe the development of a new class of water- soluble HP Xe biosensors that use a 
pseudorotaxane to encapsulate HP Xe and can be imaged using a HyperCEST pulse sequence. The 
modular nature of the probes and their facile synthesis should allow for the rapid development of 
targeted molecular probes for HP Xe MRI (Figure 1) 
 
Figure 1.1:Proposed binding of Xe via formation of a ternary complex and detection via 
HyperCEST 
Until recently, the hollow, ball-shaped molecular cages, known as cryptophanes, appeared to be 
privileged structures in the field of HP Xe imaging.26−28 Cucurbit[6]uril (CB6) and cucurbit[7]uril 
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(CB7) have also been reported as HP Xe probes,11,29-30 but the larger cucurbit[8]uril (CB8) does not 
show any affinity for Xe. α, β, and γ-cyclodextrins (CDs), which are truncated cone-shaped 
macrocycles composed of six, seven, or eight D-glycopyranoside units, are some of the most 
commonly used hosts in supramolecular chemistry,31 and they would be ideal components of 129Xe 
probes because they are nontoxic and water soluble (Figure 2).  
Unfortunately, either α, β, and γ-CD fail to bind Xe in aqueous media or the reversible binding has 
too fast of an exchange rate to form a distinct peak that is observable by129Xe NMR at room 
temperature.32,33 We hypothesized that macrocycles that were too large to bind Xe on their own, 
such as CB8, β-CD, and γ-CD, could be threaded with long alkyl chains to create pseudorotaxane 
complexes that were capable of forming a ternary complex with Xe (Figure 1).34 Rotaxanes are 
well-known supramolecular species composed of a molecular axle that is threaded through a tube-
shaped host, creating a noncovalently bound structure. To serve as a Xe cage, the inner diameter of 
the rotaxane macrocycle must be large enough to fit both the molecular axle and a Xe atom in its 
hydrophobic core. However, a macrocycle that is too large would not be detectable using 
HyperCEST because the Xe would exchange in and out of the host at a rate that is too high to 
support HyperCEST detection. Prior to this work, the only precedent for the formation of this kind 
of ternary complex with Xe was reported by Cohen, who showed that a pillararene could 
simultaneously bind hexane and Xe.35 To test the above mentioned hypothesis, we designed a series 










RESULTS AND DISCUSSION 
Three cucurbiturils (CB6, CB7, and CB8) and three cyclo- dextrins (α, β, and γ-CD) were chosen 
as the host molecules. These six macrocycles were threaded with 8- and 10-carbon molecular 
threads that contained terminal ethylimidazolium groups, which served to enhance the water 
solubility of the hydrophobic alkanes and enabled facile detection by mass spectrometry (1 and 
2).36 In all of the cases studied, the rapid formation of threaded complexes was observed by mass 
spectrometry and 1H NMR, though most cases showed rapid host−guest exchange on the NMR 
time scale. Analysis by 129Xe NMR identified the promising scaffolds 
that combined the desired attributes of facile synthesis with MR detectability via HyperCEST. For 
the HP Xe studies, we used a custom-built fritted phantom inside a custom dual-tuned 1H/129Xe 
radiofrequency (RF) coil to acquire all free induction decay (FID) spectra. The aqueous solutions 
of the pseudor- otaxanes were placed inside the fritted phantom, and HP Xe was introduced below 
the fritted phantom, creating micro- bubbles that percolated vertically through the sample. A series 
of saturation prepulses at a variety of chemical shift offsets were loaded into user interface software 
of the GE Achieva 3T MR scanner. Spectra with different saturation prepulses were acquired 
approximately every 6 s. 
As expected, irradiation at +128 ppm (relative to the peak corresponding to xenon gas) produced a 
67% depletion for a sample of unthreaded CB6, thus confirming that our experimental method was 
reliable (Table 1, entry 1). However, it should be noted that contrary to previous reports, we did 
not observe a HyperCEST signal for CB7 (entry 4).37 None of the studies with cucurbituril-derived 
pseudorotaxanes produced any HyperCEST attenuation (entries 2−3, 5−6, and 8−9), likely 
indicating that there is not sufficient space to bind xenon in the cavity of the supramolecular 
complex. Gratifyingly, we found that cycodextrin-based pseudorotax- anes reversibly encapsulated 
Xe and could be detected by 129Xe magnetic resonance spectroscopy. HyperCEST depletions of 
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43 and 52% were observed for the γ-CD containing C8 and C10 diethylimidazolium bars (2 ⊂ γ-
CD and 1 ⊂ γ-CD, respectively, entries 17 and 18). 





1 CB6 164 67% +128 
2 + 2 52 0% - 
3 + 1 41 0% - 
4 CB7 279 0% - 
5 + 2 82 0% - 
6 + 1 79 0% - 
7 CB8 479 0% - 
8 + 2 138 0% - 
9 + 1 125 0% - 
10 α-CD 174 0% - 
11 + 2 52.1 0% - 
12 + 1 48.1 0% - 
13 β-CD 262 0% - 
14 + 2 85.1 0% - 
15 + 1 74.2 0% - 
16 γ-CD 427 0% - 
17 + 2 170.1 43% +128 
18 + 1 176.2 52% +128 
aVolume of xenon binding pocket based on computed host and pseudorotaxane structures. See the 
Supporting Information for details. 
bDepletion of the peak corresponding to unbound Xe. Samples were dissolved in water (2 mL, 10 
mM), and one-dimensional 129Xe spectra were recorded. HyperCEST spectra were subsequently 
acquired using a series of off-resonance pulses varying by 5 ppm 
Table 1-1: Characterization and HyperCEST Data for Pseudorotaxanes 
Like CB6, the maximum HyperCEST depletion for the γ-CD pseudorotaxanes occurred when the 
samples were irradiated at a frequency of +128 ppm, relative to the Xe gas-phase signal. 
9 
 
HyperCEST depletion spectra for 1 ⊂ γ-CD are shown in Figure 3. Importantly, the magnitude of 
the HyperCEST depletion for 1 ⊂ γ-CD was comparable to that of CB6, a xenon cage that we have 
recently shown to be amenable. 
to in vivo HP Xe MRI.12 1H NMR also confirms the formation of the ternary 
pseudorotaxane−xenon complex [(Xe·1) ⊂ γ-CD, Figure 4]. Formation of the pseudorotaxane with 
γ-CD and 1 can be monitored by an upfield shift in the triplet corresponding to the proton attached 
to the C3 position in the cyclodextrin. This proton is positioned on the interior of the macrocycle, 
so it is shielded when the pseudorotaxane forms. Subsequent binding of xenon further shifts the 
C3−H peak upfield, indicating that the xenon also binds to the interior of the macrocyclic host. No 
shifts of the protons corresponding to the ethylimidazolium groups of the host pseudorotaxane are 
observed. Whereas these spectra might not, by themselves, be definitive evidence for the formation 
of the proposed ternary complex, when considered in the context of the HyperCEST data shown in 
Figure 3, the data are consistent with the formation of a ternary complex. Importantly, the control 
experiments in entries 10, 13, and 16 of Table 1 show that xenon does not form a binary complex 
with cyclodextrins that can be detected by HyperCEST.  
The formation of the pseudorotaxanes was observed by mass spectrometry. Additionally, NMR 
and isothermal calorimetry (ITC) binding studies were used to characterize the most promising 
pseudorotaxanes.38 The association constant, Ka, for 1 ⊂ γ-CD was determined by NMR in pure 
water to be 2.94 × 103 M−1 at 300 K, and the Ka for 2 ⊂ γ-CD was determined to be 4.10 × 103 M−1 
at 300 K. ITC was also used to corroborate the Ka for 1 ⊂ γ-CD in pure water, 1.00 × 104 M−1 at 
300 K. Importantly, ITC in fetal bovine serum also showed formation of the pseudorotaxane 
complex, though the binding affinity was two orders of magnitude lower, 1.01 × 102 M−1 at 300 K. 
This indicates that the pseudorotaxanes form in complex, biological media, so they could find 






Figure 1.3: Free Induction Decay (FID) spectra of 10 mM aqueous solution of 1⸦γ-CD following 
off-resonance (+255 ppm, left) and on-resonance (+128 ppm, center) HyperCEST pulses. 
HyperCEST depletion z-spectrum of a 10 mM aqueous solution of 1⸦γ-CD (right).  Each data point 
indicates the HyperCEST depletion when the molecule is irradiated with a pulse at a given chemical 
shift off-set.  
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The data shown herein indicate that two parameters can be used to predict the ability of a 
pseudorotaxane to form a ternary complex with xenon. First, the pseudorotaxane must form a 1:1 
host−guest complex. Our data does not probe a wide range of host−guest association constants, but 
it appears that an affinity on the order of 103 is sufficient. 
Second, the pseudorotaxane must contain an internal hydrophobic cavity with a volume of 
approximately 164−176 Å3 (Table 1, entries 1, 17, and 18). These parameters explain why all the 
pseudorotaxanes with hosts besides γ-CD failed to bind Xe; they simply did not have a large enough 
internal cavity. α-Cyclodextrin also has a cavity that is of sufficient size to bind Xe (174 Å3, entry 
10), and this binding has been previously reported;32 however, the chemical shift of the bound 
complex is 3 ppm away from the peak corresponding to dissolved xenon, too close to be observed, 
as our HyperCEST pulse is ∼10 ppm wide. 
 
Figure 1.4: 1H NMR spectra indicating the formation of the ter-nary complex (25 oC, [γ-CD] = [1] 
= 100 mM.)  A/ 1H NMR spectrum of γ-cyclodextrin.   B/ 1H NMR spectrum after addition of 1 
equiv of 1.  C/ 1H NMR spectrum after addition of 1.5 atm xenon  
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It should be noted that the pseudorotaxanes that we are describing herein are markedly distinct from 
the rotaxane-based HP Xe probes that have been recently described by Dmochowski, Pines, and 
Francis.19,39 In those cases, a threaded CB6 structure was synthesized that could not bind Xe, but 
when the thread was severed, either by action of an enzyme or by a change in pH, the CB6 was 
released, and a signal was observed. These probes represent a creative approach for synthesizing 
“turn on” HP Xe sensors; contrastingly, the rotaxanes that we describe herein are a new scaffold 
that is capable of producing an HP Xe signal via formation of a ternary binding motif The data 
shown in Table 1 and Figure 3 were obtained using a Phillips Achieva 3T clinical whole-body MR 
scanner, which provides significant advantages over conventional NMR spectrometers, namely, the 
ability of performing whole-body imaging experiments. These advantages come with some trade- 
offs, specifically the ability of acquiring HyperCEST depletion spectra with a Lorenzian fit line, 
such as in the data processed for cryptophane and cucurbituril agents, as demonstrated by others 
using high-field, high-resolution NMR spectrome- ters.11,39−42 However, the use of a clinical 
scanner bodes well for eventual clinical translation of our techniques to in vivo experiments, which 
we recently demonstrated using a non- targeted 129Xe contrast agent.12  
In conclusion, we have discovered a novel method for synthesizing potential HP Xe probes using 
pseudorotaxane structures of γ-CD. These supramolecular complexes form a novel ternary structure 
in the presence of HP Xe, which can be detected via 129Xe MR spectroscopy. Current efforts in 
our laboratories are dedicated to synthesizing rotaxane-based probes that will not dissociate and in 
the application of these new probes for targeted molecular imaging. 
NMR HyperCEST Detection. Natural abundant 129Xe gas 
was polarized to 26−30% using a Xemed polarizer (Xemed, Durham, NH). Next, 1.0 mL of sample 
was drawn into a glass frit cell using a syringe. The cell was then inserted into a custom RF coil 
tuned to the Larmor frequency of 129Xe (35.33 MHz) at 3T, where HP 129Xe gas was introduced 
to the vessel from the Tedlar bag in the pressure chamber, which was pressurized at 35 kPa above 
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atmosphere. The solution was mixed with HP 129Xe gas as it passed through the fine fritted disc 
and produced several microbubbles, which continuously dissolved into solution and exited the 
vessel through the outflow tube. The concentration of 129Xe at any point during the experiment 
was between 1 and 10 mM. A Philips Achieva 3T clinical scanner was used to collect all NMR 
spectra. The RF pulse length was determined with the use of ref B1, a parameter of Philips MR 
scanners. The pulse length and flip angle were used to calculate the amplitude of the RF pulse and 
field strength. In this study, the B1 field strength was determined by the scanner to be 15.9 μT. In 
the acquisition of NMR spectra, a pulsed saturation pre-pulse train consisting of 96−20 ms 3-lobe 
sinc pulses with 0 ms pulse intervals was applied at various chemical shift offsets. 
Free induction decay (FID) spectra were acquired at various chemical shift frequency offsets, 
approximately 5 ppm apart. Each FID spectra was acquired approximately 6 s apart. Off- resonance 
FID spectra were obtained quarterly in this series and acquired with a saturation pre-pulse at +271 
ppm off- resonance from the gas-phase peak. A HyperCEST depletion spectrum was collected for 
each sample (see the Supporting Information) by measuring HyperCEST depletion at various 
frequency offsets from the Xe gas-phase peak. A minimum of three spectra were obtained at each 
of the various chemical shifts, and a plot of the mean signal depletion as a function of the frequency 
of the chemical shift offset (z-spectrum) was produced. The mean signal-to-noise ratio (SNR) 
obtained from all control spectra for individual samples was used in the measurement of signal 
depletion. The SNR for each spectrum was calculated using MATLAB (MathWorks, Natick, MA). 
To measure signal depletion, the mean HyperCEST saturation spectrum SNR was subtracted from 
the mean control spectrum SNR. This difference was then divided by the mean control spectrum 
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1.2 SUPPORTING INFORMATION 
Cyclodextrin-based Pseudorotaxanes: Easily Conjugatable Scaffolds for Synthesizing 




Substrates, including 1-ethylimidazole, 1,8-dibromooctane, 1,10-dibromodecane, 1,5-
dibromopentane, cucurbit[6]uril, cucurbit[7]uril, cucurbit[8]uril, -cyclodextrin, -
cyclodextrin and -cyclodextrin were purchased from Sigma-Aldrich, Fisher Scientific, and 
TCI chemicals. All reagents were stored under an inert atmosphere before use. Unless 
otherwise noted, all reactions were performed under N2. 
 
Instrumentation  
NMR spectra were obtained using a Bruker Avance 300 MHz and 400 MHz spectrometers. 
Low resolution mass spectrometry was performed using a Shimadzu LRMS-2020.  High 
resolution mass spectrometry was performed using a Thermo Scientific LTQ Orbitrap XL™ 












Synthesis of guest molecules  
  Synthesis of C10 diethylimidazolium guest, 1 
 
1-Ethylimidazole (1.942 mL, 20 mmol) and 1,10-dibromodecane (1.792 mL, 8 mmol) were 
dissolved in toluene (15 mL) and refluxed for 12 hours. Once complete, the toluene was 
decanted, and the crude product was washed with diethyl ether (3 x 20 mL) and dried under 
vacuum until a white solid product formed (2.20 g, 56% yield). Spectral data matched the 
reported values.1  
1H NMR (400 MHz, DMSO-d6) δ 9.34 (s, J = 1.7 Hz, 2H), 7.85 (dd, J = 5.8, 1.9 Hz, 4H), 4.20 
(dq, J = 14.3, 7.3 Hz, 8H), 1.79 (p, J = 7.3 Hz, 4H), 1.43 (t, J = 7.3 Hz, 6H), 1.25 (s, 12H). 
13C NMR (101 MHz, DMSO-d6) δ 136.1, 122.8, 122.6, 49.2, 44.6, 29.8, 29.2, 28.8, 25.9, 15.5. 










Figure 1.6: 13C NMR of Guest 1  
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  Synthesis of C8 diethylimidazolium guest, 2 
 
1-Ethylimidazole (1.06 mL, 11 mmol) and 1,8-dibromooctane (808.7 µL, 4.4 mmol) were 
dissolved in toluene (15 mL) and refluxed for 12 hrs. Once complete, the toluene was decanted, 
and the crude product was washed with diethyl ether (3 x 20 mL) and dried under vacuum until 
a white solid product formed (0.51 g, 38% yield). Spectral data matched the reported values.1 
1H NMR (400 MHz, DMSO-d6) δ 9.40 (s, 2H), 7.86 (d, J = 1.7 Hz, 4H), 4.11 (m, 8H), 1.79 (p, 
J = 7.2 Hz, 4H), 1.42 (t, J = 7.3 Hz, 6H), 1.12 (m, 8H). 
13C NMR (101 MHz, DMSO-d6) δ 136.2, 122.8, 122.6, 49.2, 49.6, 29.7, 28.6, 25.8, 15.6. 




















Synthesis of pseudorotaxanes using cucurbit[n]urils and bars 
 10 mM stock solutions of cucurbit[n]uril (n= 6, 7, 8) and the guests were prepared using D2O 
as the solvent. Using the above stock solutions, 0.25 mL of the host and 0.25 mL of the guest 
were mixed inside a GC vial. The threading of the guest into the host was achieved by heating 
the solution inside the GC vial to 85 oC for 3 min. This solution was then cooled to room 
temperature and transferred to an NMR tube.  While the initial CB solutions were cloudy, the 
final pseudorotaxane solutions were clear and homogeneous. 1H NMR spectra were then 
acquired at 300 K. 1H NMR was performed to see the movement of the alkyl protons in the 











































































































































































































































































































































Synthesis of Pseudorotaxanes using α, β, and γ-CDs 
 10 mM stock solutions of cyclodextrins (α, β, γ) and the guests were prepared using D2O as the 
solvent. Using the above stock solutions, 0.25 mL of the host and 0.25 mL of the guest were 
mixed inside a GC vial. The threading of the guest in to the host was achieved by heating the 
solution inside the GC vial to 40 oC for 3 min. This solution was then cooled to room 
temperature and transferred to a NMR tube. The final solutions containing the pseudorotaxanes 
were clear and homogeneous. All 1H NMR spectra were acquired at 300 K. 1H NMR was 
performed to see the movement of the alkyl protons in the guest and the movement of the 
































































































































































Determination of association constants for host cyclodextrins and guests 
           The NMR titration experiments were conducted per the following procedures.2 The host CD 
concentrations were kept constant while the guest concentration was increased periodically. 
Stock solutions of 2 mM host (cyclodextrin) and 200 mM guest were prepared. A series of 
NMR samples were prepared in 5 mm NMR tubes. The series ranged from 0.111 mM to 
200 mM.  All samples were then heated for 3 min at 40 oC to facilitate the threading of the 
guest in to the host. All samples were cooled to room temperature before the 1H NMR 
experiments.  All 1H NMR were performed at 300 K. The H-3 proton of the host CD was 
monitored. Data was processed using an Excel spreadsheet using the equation shown below. 
The plots are shown below. The data were also evaluated using the “OpenDataFit” website, 
which is an online free fitting program found at supramolecular.org.2  The two different 
analysis methods provided similar results. 




) + {[𝐻0] + [𝐺0] +
1
𝐾
− (([𝐻0] + [𝐺0] +
1
𝐾
)2 − 4[𝐻0] [𝐺0])
1
2} 
where ∆δ = change in chemical shift after the addition of the guest, [H0] = initial host 
concentration, [G0] = initial concentration, and K = association constant. ∆δ was plotted as 











































Figure 1.34: 1:1 Binding curve for the association of 1 with γ-CD. 
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Figure 1.36: 1:1 Binding curve for the association of 2 with γ-CD. 
 
 
Figure 1.37: 1:1 Binding curve for the association of 2 with γ-CD. 
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All compounds were prepared in the deionized water at a concentration of 200 µM for 
both guest and host molecules separately and as a mixture. Then they were diluted to 20 
µM (each) in a solution of methanol/water (50/50) to produce the standards for mass 
spectrometric analysis. The final solutions were infused into a Thermo Scientific LTQ 
Orbitrap XL™ (Waltham, MA, USA) mass spectrometer at a rate of 10 µL/min using 
electrospray ionization source in a positive mode. The rest of the ionization and ion optics 
parameters were as follows: sheath gas 15, auxiliary gas 3, spray voltage 5 kV, capillary 
temperature 275 °C, capillary voltage 47 V, tube lens 225 V, multipole 00 offset -5.5 V, 
lens 0 -6.0 V, multipole 0 offset -5.75 V, lens 1 -10.0 V, gate lens -46.0 V, multiple 1 offset 
-19.5 V, multipole RF amplitude 400.0 V, front lens -6.75 V. The mass spectra were 
collected using full scan mode with resolution of 30000 in the range between 100 and 
2000 amu. The spectra were averaged over at least 50 micro scans with 10.0 ms 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1.45: 1⸦β-CD (ESI+, 5 uL/min, FS, 20 uM/20 uM) – m/z 733.3298 









Determination of association constants for guest probes and γ-CD using Isothermal 
Titration Calorimetry (ITC) 
A 1000 mM solution of 1 and 100 mM solutions of γ-CD were made in water and plasma. Once 
the solutions were made, the guest solution was loaded in to the micro-syringe and the γ-CD 
solution was placed in the sample ampoule (2 ml). Lower concentrations of the host and guest 
did not provide sufficient heat flow for reliable ITC analysis.  For the titration, a 1 µl/S rate and 
21 injections were chosen.  Except for the first injection, which was 3 µl, all the other injections 
were 10 µl injections. Each titration was performed for 20 minutes with a 5-minute base line. 
For data analysis, blank titrations were performed with addition of guest 1 to DI water and 
plasma without the γ-CD. The data from the blank titration were used to subtract the heat of 
dilutions. Once the Raw heat data was obtained, the data was processed using the online 




















Figure 1.48: Analysis of ITC binding data for 1 with γ-CD in water 





Figure 1.49: Analysis of ITC binding data for 1 with γ-CD in bovine plasma 
 
Association Constant of 1γ-CD (plasma) = 1.0114 ± 0.0592 x 102 M-1 
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A series of computational studies were performed to measure the cavity size of the 
pseudorotaxanes using the Spartan 16 computational chemistry package.  A first minimization 
was performed using molecular mechanics with the MMFF force field in the gas phase. Once 
the minima were obtained, the same force field was used to run the simulation in water as the 
solvation source. After that, the semi-empirical PM3 force field was used to minimize the 
structure in the gas phase. This was followed using an energy minimization (PM3) using 
external water molecules (One water molecule of water was used per oxygen atom in the host.) 
to mimic the hydrophobic and hydrophilic interactions of the guest to the hydrophobic cavity 








α-CD -132.23 -108.96 
β-CD -448.94 -433.7 
γ-CD -778.93 -722.71 
CB[6] -198.98 -174.29 
CB[7] -234.64 -210.69 
CB[8] -370.23 -338.92 
 
Table 1-2: Calculated binding energies for pseudorotaxanes 
Molecular modeling calculations were performed using Spartan 16 for all complexes as guests 
encapsulated in the hosts to estimate the stabilization energy obtained by complexation (which 
provides an indication of the relative binding constants). Above ΔE values are given in kcal/mol. 
The following equation was used to obtain the final values:3 
                                                 ΔE = E (complex) – E(host) – E(Guest) 
External water molecules (one water molecule per oxygen in the host molecule) were used to mimic 
the solvent environment for both the hosts and the host-guest complexes. 
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Atom labels C-C distance (Ao) 
C32, C47 8.725 
C31, C47 7.318 
C20, C47 7.369 
C34, C47 6.039 
C18, C47 6.557 
C17, C47 5.805 
C19, C47 6.511 
C15, C47 5.832 
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Atom labels C-C distance (Ao) 
C32, C47 7.802 
C31, C47 6.976 
C20, C47 5.740 
C34, C47 5.322 
C18, C47 4.389 
C17, C47 4.884 
C16, C47 4.766 
C15, C47 6.154 
C57, C47 6.473 
C13, C47 8.001 
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Atom labels C-C distance (Ao) 
C14, C58 7.802 
C13, C58 6.976 
C11, C58 5.740 
C9, C58 5.322 
C4, C58 4.389 
C5, C58 4.884 
C3, C58 4.766 
C1, C58 6.154 
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Atom labels C-C distance (Ao) 
C1, C47 7.726 
C3, C47 6.481 
C5, C47 6.161 
C7, C47 5.075 
C9, C47 5.333 
C11, C47 5.256 
C13, C47 6.071 
C14, C47 6.712 
C25, C47 8.012 
C26, C47 8.876 
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Atom labels C-C distance (Ao) 
C25, C71 7.809 
C24, C71 6.389 
C19, C71 6.084 
C14, C71 5.255 
C4, C71 5.808 
C3, C71 5.340 
C2, C71 6.566 
C1, C71 6.593 
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Atom labels C-C distance (Ao) 
C40, C20 8.521 
C39, C20 7.202 
C25, C20 7.066 
C24, C20 5.895 
C19, C20 6.276 
C14, C20 5.438 
C4, C20 6.455 
C3, C20 6.089 
C2, C20 7.453 
C1, C20 7.586 
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Atom labels C-C distance (Ao) 
C6, C10 6.903 
C5, C10 5.739 
C4, C10 6.250 
C3, C10 5.493 
C2, C10 6.404 
C7, C10 6.458 
C18, C10 7.366 
C19, C10 7.791 
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Atom labels C-C distance (Ao) 
C32, C13 8.006 
C21, C13 7.552 
C2, C13 6.093 
C3, C13 5.953 
C4, C13 4.690 
C5, C13 5.155 
C6, C13 4.398 
C7, C13 5.408 
C18, C13 5.257 
C19, C13 6.569 
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Atom labels C-C distance (Ao) 
C13, C30 6.811 
C12, C30 6.102 
C11, C30 5.812 
C5, C30 5.383 
C4, C30 5.423 
C3, C30 5.094 
C2, C30 5.709 
C1, C30 5.740 
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Atom labels C-C distance (Ao) 
C35, C59 7.385 
C34, C59 6.2783 
C13, C59 6.664 
C12, C59 5.892 
C11, C59 6.763 
C5, C59 6.527 
C4, C59 7.629 
C3, C59 7.812 
C2, C59 8.992 
C1, C59 9.554 
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Atom labels C-C distance (Ao) 
C2, C19 7.907 
C3, C19 7.947 
C4, C19 9.127 
C7, C19 9.408 
C9, C19 10.558 
C23, C19 10.887 
C25, C19 12.338 
C33, C19 12.767 
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Atom labels C-C distance (Ao) 
C2, C19 9.347 
C3, C19 8.737 
C4, C19 9.309 
C7, C19 9.223 
C9, C19 10.032 
C23, C19 10.344 
C25, C19 11.233 
C33, C19 11.926 
C45, C19 12.772 
C46, C19 13.599 
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Xenon NMR studies 
Naturally abundant 129Xe gas was placed into a 1.0 L Tedlar bag and polarized to 60-80% via 
the spin exchange optical pumping (SEOP) technique using a Xemed polarizer (Xemed, 
Durham, NH, USA).  It was then placed into a Tedlar bag which was immediately moved into 
a pressurized chamber within the bore of a Philips Achieva 3.0 T clinical MRI scanner to 
preserve its polarization. The pressure inside of the chamber was maintained between 20-45 
kPa above atmospheric pressure using a pressure-sensitive ventilation device connected to a 
nitrogen (N2) source, to facilitate the flow of HP 129Xe gas from the Tedlar bag into the glass-
fritted cell containing rotaxane solution. 
Following polarization of 129Xe gas, 2.5 mL of solution (50 mM) was transferred into a custom-
made glass-fritted cell using a syringe.  The cell containing the solution was then placed inside 
of a custom-made quadrature radio-frequency (RF) coil tuned to the Larmor frequency of 129Xe 
(35.33 MHz) at 3.0 T.  The Tedlar bag, already in the bore of the MRI, was then connected to 
the cell’s inflow tube.  Once connected, the pressure-stopper on the Tedlar bag was released to 
allow for the continuous flow of HP 129Xe gas into the glass-fritted cell, which produced several 
microbubbles as it passed through the fine fritted disc, thereby dissolving into the solution.  As 
HP 129Xe gas continually flowed through the glass-fritted cell, 129Xe nuclear magnetic 
resonance (NMR) spectral data was simultaneously obtained.  The concentration of 129Xe at 
any point during the spectral acquisition was between 1-5 mM24. 
All 129Xe NMR spectra were acquired using a Philips Achieva 3.0 T clinical MRI scanner.  
Scanner software was modified for the automatic measurement of hyperpolarized chemical ex-
change saturation transfer (HyperCEST) depletion spectra.  To saturate HP 129Xe encapsulated 
within the rotaxane molecules, two different pre-pulse trains were used: the first consisted of 
16- 30 ms 3-lobe sinc pulses, while the second consisted of 16- 30 ms sinusoidal pulses, both 
with 0 ms pulse intervals.  To acquire each depletion spectrum, 37 free induction decay (FID) 
83 
 
spectra were collected at various chemical shift frequency offsets with TR = 4s.  Each FID 
spectrum was acquired using a selective 90-degree “spredrex” excitation pulse with a 9.95 ms 
duration and bandwidth of 1424 Hz (40.3 ppm at 3.0 T). 
The data sampling number was 2048, which corresponds to the spectral resolution of 0.44 ppm.  
Saturation pre-pulse frequency was automatically adjusted to range from -150 ppm to 30 ppm, 
where 0 ppm represents dissolved-phase 129Xe, with a predetermined step before each of the 
subsequent excitation pulses.  Offset frequency steps were 176.7 Hz, which correspond to 5 
ppm at 3.0 T.    
  
Figure 1.50: HyperCEST pulse sequence 
The pulse diagrams shown above were used to prepare HyperCEST depletion spectra using 
different saturation pre-pulse trains including 3-lobe sinc pulses (A) and sinusoidal pulses (B).  
Here, fj represents the frequency of saturation pulses during FID acquisition number j.  All 






Figure 1.51: Apparatus for obtain HP Xe spectra 
 
Figure 1.52: Custom-made coil and sample chamber 
The image above illustrates the continuous flow of HP 129Xe gas throughout the glass-fritted 
vessel.  As depicted, once the flow of HP 129Xe reaches the fine glass-fritted disc, numerous 
microbubbles are produced, thereby causing dissolution of HP 129Xe into solution.  The RF 
pulse is applied at the chemical shift frequency offset which corresponds to the ternary complex 




Cavity volume calculations 
Commercially available MOE4 software was used to calculate the free space in the host after 
the guest was threaded inside the CD or CB cavity, using the Assisted Model Building with 
Energy Refinement (AMBER) force field for energy minimizations and molecular dynamics. 
A custom-made active site volume script provided from MOE was used in the process.  The 
script computationally filled the void space in the pseudorotaxane with spheres having a 
volume of 2.75 A3.   The volume of the cavity was calculated as the sum of the volumes of the 
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A decacationic water-soluble pillar[5]arene (P5A) possessing a non-solvated hydrophobic core has 
been designed and synthesized. This supramolecular host is capable of binding xenon, as evidenced 
by a hyperCEST depletion experiment. Fluorescence-based studies have also demonstrated that 
xenon binds into the cavity of the pillararene with an association constant of 4.6 x 103 M-1. These 
data indicate that the water soluble pillararene is a potential scaffold for building targeted 




There is a clear and pressing need for the development of safe magnetic resonance imaging 
(MRI) contrast agents.  One possible alternative to the current Gd-based contrast agents, which 
have recently been shown to have toxicity issues, is the use of hyperpolarized xenon-129.  Inhaled 
129Xe is non-toxic, readily distributes throughout the body, and can be easily detected using a 
conventional MRI instrument with a broadband coil. We have recently shown that the 129Xe image 
of a living rat can be overlaid onto a conventional 1H image to provide selective contrast. 1  The 
key for this work was the use of the macrocyclic contrast agent, cucurbit[6]uril (CB6), which was 
injected into the animal prior to the imaging experiment.  The biodistribution of CB6 was imaged 
because the molecular host bound the inhaled 129Xe in vivo, producing a unique localized signal in 
the 129Xe magnetic resonance spectrum. Whereas Gd(III) ions produce image contrast in a 
conventional T1-weighted MR image by reversibly binding water molecules, the macrocyclic host 
reversibly bound xenon atoms and this reversible binding was selectively imaged via a saturation 
transfer pulse sequence, hyperCEST, thus providing localized contrast. 2-5   
This seminal in vivo imaging experiment serves as an important proof-of-concept; 
however, the use of CB6 was not optimal, as it is known to bind sodium and potassium ions that 
are present in vivo, and it biodistribution cannot be changed as it is difficult to chemically modify. 
6-12  Cryptophanes have also been extensively studied for their ability to bind xenon; however, they 
are notoriously difficult to synthesize, are not by themselves water soluble, and water-soluble 
derivatives such as TPCA have been recently shown to form complex aggregates in aqueous 





Figure 2.1: Comparison of Xe-binding hosts 
We have recently focused our research efforts on the development of new supramolecular 
structures for binding xenon, including the development of pseudorotaxanes that form unique 
ternary complexes with 129Xe. 17 The ideal molecular host for use in 129Xe MRI would be easy to 
synthesize in large quantities, highly water-soluble, and would reversibly bind 129Xe, as evidenced 
by a hyperCEST experiment.  Herein, we describe the design and synthesis of a cationic 
pillar[5]arene macrocycle that meets all of these criteria. 
Pillar[5]arenes (P5As), are pentameric macrocycles, synthesized by the templated Friedel-
Crafts cyclization of hydroquinone derivatives.  Since they were initially synthesized by Ogoshi a 
decade ago, 18 P5As have been used for a wide range of host-guest chemistry. 19,20  P5As contain a 
central cavity of approximately 5.8 Å3, which is comparable to other macrocycles that have been 
shown to have an affinity for xenon, such as CB6 and cryptophane-A, and recently both Cohen and 
Schroeder have shown that P5A derivatives can interact with xenon, as evidenced by conventional 
129Xe NMR and by magnetization transfer experiments. 21,22 Herein, we report the design and 
synthesis of a P5A structure that has been optimzed for its ability to bind xenon, we then quantify 
its affinity for the nobel gas, and we demonstrate the first example of hyperCEST depletion for a 
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pillararene macrocycle, thus validating its potential as a contrast agent for 129Xe MRI, and laying 
the necessary groundwork for subsequent in vivo imaging studies. 
Results and discussion 
We began our studies by computationally modelling a variety of P5A structures.  Gas phase 
energy minimized structures of pillararenes were obtained using semi-empirical computations and 
a PM3 force field. A xenon atom was then placed outside the hydrophobic core of the P5A structure, 
and the energy of the system was minimized again to model the dynamics of the two species.  
Interestingly, the simplest P5A, which was decorated with 10 methyl groups (4), failed to bind 
xenon in this computational experiment.  Additionally, P5A structures that were decorated with 
longer alkyl chains also failed to bind xenon (e.g. 2).  In both of these cases, the molecular dynamics 
experiments showed that the alkyl arms of the P5A structures preferred to fold onto themselves via 
hydrophobic collapse.  Contrastingly, the P5A structure containing 10 cationic imidazolium groups, 
opened like the petals of a flower, revealing the hydrophobic core.  The aforementioned gas phase 
molecular dynamics experiment predicted that this decacationic P5A should be an excellent 
candidate for binding xenon.  Moreover, we predicted that this highly charged compound should 






Scheme 2-1: Synthesis and computed structures of neutral and decacationic pillararenes 
We further used molecular dynamics simulations in an aqueous environment to predict the 
binding and hydrophobicity of the host structure.  These simulations were performed using 1000 
iterations with 0.001 ps time step size for discretizing the equations of motion for unconstrained 
bond lengths, which allows free motion. The simulations were conducted in the presence of 1,830 
water molecules within a P1 type cell with x, y, z distances of 90 Å, 90 Å, 90 Å (Figure 2).  As 
before, the xenon atom was computationally placed outside the hydrophobic cavity of the P5A and 
was observed to rapidly associate with the hydrophobic core during the moleculear dynamics 
simulation, thus indicating that the cationic P5A was capable of binding a single xenon atom in 
aqueous solution.  As shown in Figure 3, these computations prediceted that the hydrophobic core 
of the P5A was not a good host for water molecules, thus it was capable of binding a xenon atom  





































































































Figure 2.2: L to R: molecular dynamics simulations of Xe and 3 using 1830 water molecules; 
computed hydrophobic surface of 3 is shown in red; Xe binds ot the hydrophobic surface of 3 
As previously shown in the Scheme 1, the synthesis of the water-soluble P5A commenced 
with the Friedel-Crafts cyclization of 1,4-bis(2-bromoethoxy)benzene in dichlorethane.26  As 
previously reported by Huang, this solvent is crucial for the synthesis of pillara[5]arenes because 
it serves as a template, allowing for high yields of the cyclic oligomer and preventing polymeric 
products.  Subsequently, the 10 imidazolium ions were added in a single step, and the decacationic 
pillararene was isolated by recrystallization from methanol and diethyl ether.  
1H NMR spectroscopy of the pillararenes confirmed the computationally predicted 
structures that were previously shown (Figure 3). The decabromo-P5A (2) was characterized by 
sharp peaks in the 1H NMR spectrum, indicating that its structure was rigid and compact, whereas 
the 1H NMR spectrum of the decacationic-P5A (3) contained broad peaks, indicating that the charge 




Figure 2.3: Stacked 1H-NMR of 2 in CDCl3 (top) and 3 in DMSO-d6 (bottom). Product peaks are 
highlighted 
Fluorescence quenching by xenon provided a sensitive method for measuring Xe binding, 
even at substoichiometric Xe concentrations.  P5As are weakly fluorescent, and titration of aqueous 
xenon into the a solution of 3 induced quenching. 23  (See supporting information for experimental 
details.)  The data from the fluorescence quenching experiments was plotted using a non-linear 







Figure 2.4: Left image; Fluorescence quenching phenomena when Xe (aq) added into a solution 
of WSP5A (aq) in phosphate buffer.(Gaussian curve smoothing using Origin lab software), right 
image; occupancy curve with respect to the concentration of Xe (aq) used 
Dmochowski has performed similar fluorescence quenching studies for measuring the affinity of 
xenon for the water-soluble cryptophane shown in Figure 1, 14 reporting an association constant 
(Ka) of 1.7 x 104 M-1. The association constant that we obtained for 3 was one order of magnitude 
lower 4.6 x 103 M-1, but it should be noted that 129Xe contrast agents do not necessarily have to bind 
xenon with high affinity; the hyperCEST experiment capitalizes on reversible binding of xenon in 
a supramolecular host.  The quenching data show a maximum occupancy of 1, which is a clear 
illustration of single-site binding.  
 Finally, the potential application of 3 as a 129Xe contrast agent was assessed.  The z-
spectrum of an aqueous solution of 3 is shown in Figure 5.  The characteristic peak at -80 ppm 
corresponds to the key 129Xe@3 complex.  The hyperCEST depletion in this experiment is 30%, 
which should be sufficient for imaging studies. 25 It is also likely that this result could be improved 
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by modifying the pre-pulse train parameters, which should allow for better depolarization of the 
encapsulated Xe.  Importantly, these data were acquired in a Phillips Achieva 3T MRI scanner, 
indicating that this technology can likely be translated for preclinical and clinical imaging studies. 
Determination of HyperCEST depletion of water-soluble P5A 
Naturally abundant 129Xe gas was polarized to 45-50% using a Xemed polarizer (Xemed, Durham, 
NH). 50 mg water-soluble pillar-5-arene dissolved in 4 ml of DI H2O. 0.1 ml of DMSO was added 
into the sample to prevent foaming inside the glass frit cell. Then, 2.0ml of the sample was drawn 
into a glass frit using a syringe. The glass frit cell placed in the quadrature custom-built RF coil 
tuned to the Larmor frequency of 129Xe at 3T (35.33 MHz). The 0.5 lL Tedlar bag filled with 
hyperpolarized 129Xe was connected to the frit shoulder and placed in the pressure chamber, which 
pressurized at 24 kPa above the atmosphere. As HP  129Xe flowed through the frit membrane, it 
produced microbubbles, which facilitated dissolution of Xe. 
A Philips Achieva 3T clinical MRI scanner was used to measure all NMR spectra. The saturation 
pre-pulse train of 16 3-lobe sic pulses with a duration of 30 ms and with 0 ms pulse intervals was 
applied at various chemical shift offsets concerning the dissolved phase peak. The bandwidth of 
one 3-lobe sinc pulse of 30 ms duration is equal to 3 ppm. Therefore, each following pre-pulse train 
was applied 3 ppm apart from the frequency of the previous train. Following each saturation train, 
the FID spectrum was acquired. The spectral region from -150 ppm to 150 ppm was studied. The 
spectral bandwidth was equal to 32 kHz. The data sampling number was similar to 2048 yielding 
a spectral resolution of 0.44 ppm. A HyperCEST depletion spectrum was recalculated from the 
measured spectra at various frequency offsets from the Xe dissolved phase peak. The 129Xe  NMR 
spectra were analyzed using MATLAB (MathWorks, Natick, MA). 
The obtained HyperCest depletion spectrum was denoised using a Fast Fourier Transform Low 
Pass parabolic filter. The Pass Frequency was equal to 0.04 ppm-1, and the Stop Frequency was 
equal to 0.11 ppm-1. Following denoising, the obtained HyperCEST spectrum fitted by two peaks 
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of Lorentzian shapes. The processing of the HyperCEST spectrum was done in the OriginPro 2016 
software (OriginLab Corp., Northampton, MA). 
 
Figure 2.5: Left, HyperCEST depletion spectra for Xe binding in water-soluble pillar[5]arene. 
Right, energy minimized molecular model of Xe-bound P[5]A with the use of molecular dynamics. 
The obtained depletion spectrum had a pillar-5-arene peak at -80 ppm. This is approximately 10 
ppm upfield compared to the cucurbit[6]uril (CB6) peak position. After denoising, the peak 
amplitude decreased by 4%. Although the depletion was just 30 %, that is approximately 2.7 times 
smaller than CB6, and this supramolecular cage is a promising Xe biosensor. This result could be 
improved by modifying the pre-pulse train parameters which allow better depolarization of Xe 
inside the cage. The obtained hyperCEST depletion spectra undoubtedly show that the WSP5A 







We have successfully designed and synthesized a water-soluble pillar[5]arene that is capable of 
binding xenon, and we have characterized the xenon affinity by both fluorescence quenching 
titrations and hyperCEST.   Subsequent efforts in our laboratories will be dedicated to the synthesis 
of functionalized P5A structures, in order to create targeted contrast agents, and the use of these 
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2.2 SUPPORTING INFORMATION 
 
Deca methyl imidazolium pillar[5]arene as a viable contrast agent for hyperCEST 129Xe MRI 
Experimental Section 
Reagents 
Substrates, including CBr4, dry acetonitrile, dry 1,2-dichloroethane, boron trifluoride ethane, 
tri phenyl phosphine, methyl imidazole were purchased from Sigma-Aldrich, Fisher Scientific, 
and TCI chemicals. All reagents were stored under an inert atmosphere before use. Unless 
otherwise noted, all reactions were performed under N2. 
 
Instrumentation  
NMR spectra were obtained using a Bruker Avance 300 MHz and 400 MHz spectrometer. Low 
resolution mass spectrometry was performed using a Shimadzu LRMS-2020.  High resolution 
mass spectrometry was performed using a Thermo Scientific LTQ Orbitrap XL™ instrument. 
Fluorescence spectra was obtained using Shimatzu Fluorimeter and UV-Vis data was obtained 






Synthetic route for the synthesis of Water soluble pillar[5]arene 
 
 
The above molecule was synthesized according to the literature procedures1, with further 





  Synthesis of brominated monomer, 1 
 
A solution of 1,4-bis(2-hydroxyethoxy)benzene (10.0 g, 50.4 mmol) and triphenylphosphine 
(31.5 g, 120mmol) in dry acetonitrile (250 mL) was cooled in an ice bath. Under vigorous 
stirring, carbon tetrabromide (39.8 g, 120 mmol) was slowly added in four portions. In every 
addition the solution immediately turns bright yellow and with stirring returns back to its 
colorless form. On the final addition the solution stays cloudy. The mixture was stirred at room 
temperature for 4 hours and 20 minutes. Then cold water (200 mL) was added to the reaction 
mixture to give white precipitation. The precipitate was collected, washed with another 200 ml 
of cold water followed with methanol/water (3:2, 3 × 100 mL). The collected white solids were 
dried under vacuum for 24 hours and used without further purification. (14.5 g, 97%). 1H NMR 
and 13C NMR was performed using CDCl3. 1H NMR (400 MHz, Chloroform-d) δ 6.89 (s, 4H), 
4.27 (t, J = 6.3 Hz, 4H), 3.64 (t, J = 6.3 Hz, 4H). 13C NMR (101 MHz, Chloroform-d) δ 153.5, 














  Synthesis of deca-brominated pillar[5]arene, 2 
 
A solution of 2 (3.37 g, 11.5 mmol) and paraformaldehyde (0.349 g, 11.5 mmol) in 1,2-
dichloroethane (50 mL) was cooled with ice bath. Boron trifluoride etherate (3.26 g, 23.0 
mmol) was added to the solution and the mixture was stirred at room temperature for 1 hour. 
Between the 1 hour the reaction undergoes various color changes. All color changes are shown. 
The reaction mixture was then washed with water (2 × 50 mL), the further washes were done 
using saturated sodium bicarbonate (2 x 50 ml) and brine solution (2 x 50ml). The organic layer 
was dried with Na2SO4. The solvent was evaporated to provide a crude product. The crude 
product was pure; hence no further purification was needed. ( yield 85%). 1H NMR and 13C 
NMR was performed using CDCl3. 1H NMR (400 MHz, Chloroform-d) δ 6.91 (s, 10H), 4.23 
(t, J = 6.3, 5.1 Hz, 20H), 3.84 (s, 10H), 3.63 (t, J = 5.6 Hz, 20H). 13C NMR (101 MHz, 
















Synthesis of deca methyl imidazolium pillar[5]arene, 3 
 
A mixture of 3 (1.68 g, 1.00 mmol) and N-methylimidazole (1.64 g, 20.0 mmol) in toluene (25 mL) 
was stirred in a 40 mL pressure tube at 120 ºC for 24 hours. The reaction was performed multiple 
times using a round bottom flask, but the reaction never worked. After cooling, the solvent was 
removed by evaporation and the residue was recrystallized from ethanol/diethyl ether (1:2) to give 
a white solid (2.1 g, 87%). 1H NMR and 13C NMR was performed using DMSO-d6. 1H NMR (300 
MHz, DMSO-d6) δ 9.17 (br, 10H), 8.11 (s, 10H), 7.44 (br, 11H), 6.72 (br, 10H), 4.72 (br, 21H), 














Mass spectrometry of the water soluble P5A 
 
Figure 3.7: Mass spectrum of 3 for [M − 3Br]3+ Calculated C95H121O10N20Br7 754.1270 
 





Figure 3.9: Mass spectrum of 3 for [M − 6Br]6+ Calculated C95H121O10N20Br4 336.9378 
 
 




Saturated Aqueous Xenon Solutions for Fluorescence Quenching Experiments.   
Deionized water (25 ml) was added to an acid washed 50 mL round bottom flask.  The flask was 
capped with a septum, bubbled with nitrogen for 20 minutes, and then high vacuumed through a 
22-gauge needle for 5 minutes.  After degassing, the needle was pushed to the bottom of the flask, 
and xenon was bubbled through the solution for 5 minutes.  A 26-gauge needle was used to relieve 
excess pressure.  Both needles were removed, and the solution was set aside.  Next, a Chemware 
TedlarTM gas sampling bag with a septum valve (6” x 6”, Fisher Scientific) was connected by ¼” 
tubing and a three-way stopcock to both a xenon tank and a needle.  The entire system was 
vacuumed through the needle using a separate round bottom flask, its septa, and the house vacuum 
line.  The Tedlar bag was filled with xenon, its nozzle closed, and the three-way stopcock was 
removed.  The needle was placed directly onto the tubing connecting the Tedlar bag, and then 
pierced through the septum into the headspace of the xenon solution round bottom flask.  The 
system was placed into a 37̊C incubator for a few hours to equilibrate2. 
   
Figure 3.11: The above figures represent the experimental setup for obtaining the saturated Xe 




WSP5A Fluorescence quenching of WSP5A with Xenon 
A 5.1 x 10-4M stock solution of P5A in deionized water was made using a 100 mL volumetric flask 
and added into a 100 mL round bottom flask with septum.  The round bottom flask was bubbled 
with nitrogen for 5 minutes, and then high vacuumed for 5 minutes in order to degas the solution.  
The same dilution and degassing process was used to prepare a 1 x 10-3M phosphate buffer solution.  
In a reduced volume cuvette with a septum seal (1.5mL, 1cm path length, Starna Cells), stock 
solution of P5A and phosphate buffer was added in order to dilute the P5A concentration to 15 μM 
at 1.5 mL.  The cuvette solution was bubbled with nitrogen for 5 minutes and vacuumed for 5 
minutes in order to ensure degassing.  Saturated aqueous xenon was added so that the Xe 
concentration varied from 0 to 9.8 x 10-4M through the titration at 1.5 mL total volume.  The cuvette 
solution was allowed to equilibrate for 15 minutes in the fluorimeter before emission spectra were 
obtained. 
Saturated xenon measurement was made by directly bubbling xenon into a degassed P5A solution 
in the cuvette for 5 minutes.  The solution was allowed to equilibrate for 15 minutes in the 





Figure 3.12: Fluorescence quenching phenomena when Xe was added in to a solution of P5A in 





Figure 3.13: Fluorescence quenching phenomena when Xe was added in to a solution of P5A in 












Xenon Occupancy Curve for WSP5A 
 The fluorescence quenching of P5A is caused by the creation of a host guest complex 
between P5A and xenon in solution according to reaction (1): 
(1)     𝑃5𝐴(𝑠𝑜𝑙′𝑛) + 𝑋𝑒(𝑠𝑜𝑙′𝑛) ⇋ 𝑋𝑒@𝑃5𝐴 










because the concentration of occupied P5A is equivalent to the concentration of xenon within the 
P5A.  In order to determine the concentration of occupied P5A, an ICE table for reaction (1) must 
be developed (shown below), where Y represents the initial concentration of free xenon in solution. 
 P5A Xe Xe@P5A 
Initial 15x10-6M Y 0 
Change -X -X X 
Equilibrium 15x10-6M - X Y-X X 
 
Substituting the equilibrium concentrations shown above in the ICE table equivalent to the known 






The X values were determined for each xenon solution concentration titrated and shown in the table 
below.  Then, they were graphed as a function of xenon solution concentration, and the occupancy 
curve was developed. 















      Xenon NMR studies 
Naturally abundant 129Xe gas was placed into a 1.0 L Tedlar bag and polarized to 60-80% via 
the spin exchange optical pumping (SEOP) technique using a Xemed polarizer (Xemed, 
Durham, NH, USA).  It was then placed into a Tedlar bag which was immediately moved into 
a pressurized chamber within the bore of a Philips Achieva 3.0 T clinical MRI scanner to 
preserve its polarization. The pressure inside of the chamber was maintained between 20-45 
kPa above atmospheric pressure using a pressure-sensitive ventilation device connected to a 
nitrogen (N2) source, to facilitate the flow of HP 129Xe gas from the Tedlar bag into the glass-
fritted cell containing rotaxane solution. 
Following polarization of 129Xe gas, 2.5 mL of solution (50 mM) was transferred into a custom-
made glass-fritted cell using a syringe.  The cell containing the solution was then placed inside 
of a custom-made quadrature radio-frequency (RF) coil tuned to the Larmor frequency of 129Xe 
(35.33 MHz) at 3.0 T.  The Tedlar bag, already in the bore of the MRI, was then connected to 
the cell’s inflow tube.  Once connected, the pressure-stopper on the Tedlar bag was released to 
allow for the continuous flow of HP 129Xe gas into the glass-fritted cell, which produced several 
microbubbles as it passed through the fine fritted disc, thereby dissolving into the solution.  As 
HP 129Xe gas continually flowed through the glass-fritted cell, 129Xe nuclear magnetic 
resonance (NMR) spectral data was simultaneously obtained.  The concentration of 129Xe at 
any point during the spectral acquisition was between 1-5 mM24. 
All 129Xe NMR spectra were acquired using a Philips Achieva 3.0 T clinical MRI scanner.  
Scanner software was modified for the automatic measurement of hyperpolarized chemical ex-
change saturation transfer (HyperCEST) depletion spectra.  To saturate HP 129Xe encapsulated 
within the rotaxane molecules, two different pre-pulse trains were used: the first consisted of 
16- 30 ms 3-lobe sinc pulses, while the second consisted of 16- 30 ms sinusoidal pulses, both 
with 0 ms pulse intervals.  To acquire each depletion spectrum, 37 free induction decay (FID) 
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spectra were collected at various chemical shift frequency offsets with TR = 4s.  Each FID 
spectrum was acquired using a selective 90-degree “spredrex” excitation pulse with a 9.95 ms 
duration and bandwidth of 1424 Hz (40.3 ppm at 3.0 T). 
The data sampling number was 2048, which corresponds to the spectral resolution of 0.44 ppm.  
Saturation pre-pulse frequency was automatically adjusted to range from -150 ppm to 30 ppm, 
where 0 ppm represents dissolved-phase 129Xe, with a predetermined step before each of the 
subsequent excitation pulses.  Offset frequency steps were 176.7 Hz, which correspond to 5 
ppm at 3.0 T.    
  
The pulse diagrams shown above were used to prepare HyperCEST depletion spectra using 
different saturation pre-pulse trains including 3-lobe sinc pulses (A) and sinusoidal pulses (B).  
Here, fj represents the frequency of saturation pulses during FID acquisition number j.  All 






Above setup was used to obtain the Xe-spectra and to obtain the final depletion spectra. 
 
The image above illustrates the continuous flow of HP 129Xe gas throughout the glass-fritted 
vessel.  As depicted, once the flow of HP 129Xe reaches the fine glass-fritted disc, numerous 
microbubbles are produced, thereby causing dissolution of HP 129Xe into solution.  The RF 
pulse is applied at the chemical shift frequency offset which corresponds to the ternary complex 
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A versatile, three component, one-pot synthesis of β and γ cyclodextrin-based rotaxanes has been 
developed, and the novel supramolecular products have been characterized. The key, end-capping 
Diels-Alder reaction can be used to synthesize 1:1, 1:2 and 2:1 rotaxane structures. The syntheses 




Mechanically interlocked supramolecular complexes, such as catenanes and rotaxanes, are 
currently used in a wide variety of applications, including catalysis, drug delivery, hydrogel 
formations, and molecular devices/machines1.  
Our interest in the field of mechanically interlocked compounds originated from our recent 
synthesis of pseudo-rotaxanes that contain hydrophobic cavities2.  We found that pseudorotaxanes 
made of a linear alkane guest and γ-cyclodextrin as a host could form ternary complexes with 
xenon, and these complexes could be detected using a CEST pulse sequence in a clinical MRI.  We 
envision this as a possible platform for the development of xenon-129 MRI biosensors, but 
rotaxanes that contain hydrophobic cavities could also be used for a variety of other applications 
involving the capture of environmental analytes or drug delivery3.  However, to improve the 
stability and biocompatibility of the supramolecular framework, we commenced a synthetic 
campaign towards the synthesis of end-capped rotaxane structures that contained a hydrophobic 
cavity. 
One of the classic methods for synthesis of rotaxanes involves the threading of a linear molecular 
guest through a cyclic macromolecular host4.  This association is then followed by a rapid and 
quantitative reaction at the two termini of the molecular thread, creating large stoppers on the ends 
of the guest and thus preventing dissociation5. Common end-capping schemes for rotaxane 
synthesis use coupling or click-type reactions that attach bulky end groups because these reactions 
are generally fast, high-yielding and can be performed in a variety of solvents6.  Herein, we present 
an efficient and general process for the synthesis of cyclodextrin-based rotaxanes using a 4+2 
cycloaddition as the end-capping step.  The method can be used to synthesize rotaxanes having a 
host: guest ratio of 1:1, 2:1, or 1:2 in high yields and high purities.  The 1:1 and 2:1 (host: guest) 
rotaxanes contain a sizeable hydrophobic cavity that can be used for the formation of ternary 
complexes with hydrophobic molecular payloads. 
130 
 
As shown in Scheme 1, a linear host compound containing terminal anthracene 1 rapidly formed 
pseudo-rotaxane complexes with β- and γ-cyclodextrins in toluene.  The pseudo-rotaxanes then 
underwent efficient end-capping cycloadditions with the furan protected maleimide, 2. 
Three classes of rotaxanes were synthesized, one with a single CD host and a guest (1:1), one 
rotaxane with two CD’s and one guest (1:2) and one rotaxane with a single CD with two guests 
(2:1). The formation of these various rotaxanes was easily verified by integrating the 1H NMR. 
 
Scheme 3-1: Reaction scheme for the complete synthesis of γ-CD rotaxane 1:1 and γ-CD rotaxane 
1:2 
The rotaxanes mentioned above were obtained through the reaction of 1 with γ-CD or β-CD in the 
proper stoichiometric amounts. To achieve the final rotaxane, first 1 was mixed with γ-CD and 
toluene was added. The complete solution was sonicated for 15 minutes and was stirred at 80-90 
°C for 1 hour to accommodate the threading of the 1 into the hydrophobic γ-CD cavity. Increased 
temperature usage allows more hydrophobic interactions with the γ-CD cavity7. 
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Additionally, the oxygens on 1 tend to form hydrogen bonding interactions with the hydroxy groups 
in the cavity of the γ-CD. The formation of this inclusion complex can be observed by the 
appearance of turbidity in the reaction mixture. Similar observations have been reported with the 
formation of poly-pseudo rotaxanes8 and have been attributed to their aggregation via 
intermolecular hydrogen bonds. 
The association constant for 1 and γ-CD was found out to be 2.5 (±0.15) x 103 M-1 using NMR 
titrations. Complexation between 1 and γ-CD was monitored through 1H-NMR as shown in figure 
S58. The main observation in 1H-NMR was shifting of the alkane hydrogens caused by the 
shielding that occurred when the complex formed. Once the complexation was completed (which 
takes approximately 1 hour) dienophile 8 was added to the reaction. The mixture was then stirred 
in the dark at reflux for 18 hours. 
 
Figure 3.1: 1H-NMR of 3 (400 MHz, DMSO-d6) 
132 
 
The completion of the reaction was physically observed by the change in colors of the reaction, due 
to the loss of conjugation in the anthracene. The final rotaxanes (3, 4 and 5) were obtained by 
vacuum evaporation of the excess toluene and placed under high vacuum overnight. As shown in 
scheme 2 the same method can be employed to form rotaxane structures  containing small molecule 
affinity tags (e.g. 7). The synthesis of dienophile-affinity tag conjugate is a straight forward SN2 
reaction, allowing for a wide variety chemical probes to be attached to the rotaxane core for 
potential application as drug delivery or molecular imaging agents. In addition, the reaction was 
performed on gram scale and the reaction yields remain the same, proving that reaction can be 
scaled up with ease. 
Interestingly, the structure of the molecular thread proved to be critical for the formation of the 
rotaxanes.   When the same reaction that is shown in Figure 1 was performed on a diene like 1, but 
containing a 12-carbon central chain, no rotaxane products were observed.  This indicates that 
hydrogen bonding between the interior hydroxyl groups of the CD and the oxygens in the ethylene 
glycol chain may play a crucial role in the formation of rotaxanes 3-7. These types of associations 
are found in cucurbit[n]urils based click chemistry.9 As shown in Scheme 1, in the presence of γ-
CD the double Diels Alder reaction produced an overall yield of 90% for the rotaxane 3, whereas 
the same reaction in the absence of γ-CD, produced only a 45% of the double Diels-Alder 
product(not shown). We hypothesize that the excellent yields for 3-7 are an example of cooperative 
capture synthesis, where the cyclodextrin acts as a cofactor that preorganizes the reagents for the 
Diels-Alder reaction, leading to increased reaction efficiency.11  
The Rotaxanes 3-5were characterized using 1H-NMR and 2-D NMR, as well as high-resolution 
mass spectroscopy. The use of DMSO as an NMR solvent has been shown to prevent the formation 
of any inclusion compounds with CDs. Thus indicating that the interlocked structure produced are  
stable rotaxanes, as opposed to labile inclusion complexes10. 
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The dienophile guest 1 contains a distinguishable singlet in the aromatic region arising from the 
proton in the middle of the anthracene core. This singlet moves from the aromatic region of the 
spectrum after the Diels-Alder reaction. In addition, two small singlets coupled to each other arise 
from the newly formed C-C bond (labeled as U-V in Figure 1). The doublet near 4.7 ppm 
corresponds to the Z-hydrogen which is directly coupled to the new U-V bond. This provides 
significant proof that the Diels-Alder reaction took place, in the presence of γ-CD. Similar NMR 
evidence is equally seen in β-CD based rotaxane systems. 
As shown in Figure 1, the ethylene protons in the guest were shifted downfield, indicating that they 
are located inside the host’s cavity. Additionally, the peaks of both the cyclodextrins or the guest 
protons are not subjected to peak broadening which designates that the molecule formed here is a 
one single inter-locked rotaxane molecule, not an inclusion complex. The most conclusive evidence 
demonstrating the formation of the rotaxane is shown in the 2D ROESY spectra of 3. The cross 
peaks are shown in Figure 2 corresponds to the ethylene protons of the guest molecule that are 
correlated with H-3 and H-5 protons of the γ-CD which are found inside the hydrophobic cavity. 
Similar ROE cross peaks were observed for β-CD based rotaxanes. 
The control reaction, in which a guest that contained Diels-Alder adducts was mixed with γ-CD, 
did not produce these cross peaks. This demonstrates that the synthesis is shown previously in 
Scheme 2 and 3 forms stable rotaxanes. While the anthracene moieties are still small enough to 
pass through the center of the CD, the Diels-Alder adducts are too bulky for the guest to de-thread, 
once it is interlocked. 
Additionally, an NOE correlation was observed, corresponding to the N-H present in the guest and 
the OH2 proton of the γ-CD that lies on the outer rim of the γ-CD (See supporting info). This 





Figure 3.2: ROESY NMR of 3 (400 MHz, DMSO-d6). The arrows point towards the regions of H3 
and H5 protons NOE correlation with C-D protons of the guest molecule. Mixing time = 500 ms 
Comparable correlations were seen for the Rotaxane with ThT groups, 10. 7 was successfully 
synthesized with a yield of 85%.  Furthermore, we have synthesized similar 1:1, 1:2 and 2:1 
rotaxanes using β-cyclodextrin as a host-structure, similar characterizations were acquired along 
with mass spectroscopy to confirm their structures.  
Analysis of large rotaxanes which exceed 2000 Da were analyzed using a Waters Synapt G2 HDMS 
mass spectrometer with resolution of 1000, in the mass range of 100 to 5000 m/z. Mass specta for 
compounds 3, 4 and 5 were obtained via lower capillary voltages, while higher capillary voltages 
were used for 10 which is a much larger and heavier compound. The usage of more power was due 





Scheme 3-2: Reaction scheme for the complete synthesis of ThT-rotaxane 1:1 and ThT-rotaxane 
1:2 
We can observe signals with isotopic pattern and mass accuracy for the expected 3 with two charges 
[M+2H]2+ monoisotopic m/z 1010.3765 (2.67 ppm) for the for the formula C92H122O46N4. The 
spectrum also has signals related to [M+H] + monoisotopic m/z 2019.7424 (1.04 ppm). In the same 
m/z region signals are observed for a non-covalent dimer [2M+2H] +.  
For 4 The mass spectrum shows a base peak with 1959.0930 Zooming into this region we could 
observe signals with isotopic pattern and mass accuracy for the expected compound with two 
charges [M+2H]2+ monoisotopic m/z 1658.5902 (3.07 ppm) for the for the formula C140H202O86N4. 
The spectrum for 7 shows signals with mass accuracy and isotopic pattern for [M+2H]2+. The 
monoisotopic m/z 1980.6952 has -1,87 ppm mass accuracy for the theoretical m/z of 7. Reason for 
this behavior is that higher voltages must be used for fragmentation, which results in losing the 
molecular ion peak, but the monoisotopic m/z confirms that the rotaxane is present. The above-
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mentioned mass spectroscopy data proves that the rotaxanes were stable and formed as mentioned 
in scheme 1 and 2. Furthermore, β-CD based rotaxanes shows mass adducts that matches the 
theoretical mass adducts, hence we can conclude that both rotaxanes types were successfully 
synthesized.  
Computational studies were performed using commercially available MOE software. The same 
software was used to design the supramolecular compounds in 3-D space, energy minimizations, 
dynamics, and docking. Energy minimizations were conducted using the MMFX94 force field22, 
with an R-field of 1.80. A unit cell was created around the molecule with a cell size of 43.321 Å in 
x, y, z directions.  Rigid water molecules were chosen, with a gradient of 0.001 RMS kcal/mol/Å. 
Complex name ΔE Complex (stabilization energy) / 
[kcal/mol]  
ΔG binding (final docking 
score) / [kcal/mol] 
1 and γ-CD (1:1) -8.0068 -6.9883 
1 and γ-CD (2:1) -8.5634 -8.2360 
3 -15.6887 -9.7994 
4 -17.6590 -8.1153 
10 -33.2087 -8.8183 
Table 3-1: Stabilization energies and docking scores of complexes 
As given in table 1, the molecular dynamics data confirms that 7 has the lowest negative ΔE 
Complex which means that 7 has the highest stability. Docking results further explained the reason 
behind this. After docking the ThT rotaxane into the γ-CD cavity. The complex arranged in a very 
orderly manner wrapping around the CD cavity as given in figure 3 which explains the low 




Figure 3.3: Images of 3 (to the left) and 10 (to the right) after docking using MOE software, the 



















Figure 3.4: from top to bottom, energy minimized molecular models of γ-CD rotaxane 1:1, γ-CD 




Figure 3.5: Stacked image of methylimidazolium guest, 1:1 γ-CD rotaxane and complexation of 
the host and the guest in 1:1 ratio 
A 16-Carbon aliphatic bar with an imidazole polar head-group was chosen as a molecular mimic 
to “Perifosine” to examine the binding properties of the Rotaxane complex. Similar compounds in 
the literature exhibit the ability to stabilize charged species in DMSO due to stabilization by etheric 
oxygens at the center of the bar threaded inside the cyclodextrin. Given in figure 5 are the NMR 
spectra supporting this conclusion, showing shielding of the charged Imidazole head-group and 
nearby protons indicating inclusion of the head-group into the rotaxane complex in DMSO. We 
further hypothesize that in aqueous solution, hydrophobic interactions will predominate, and drive 
the aliphatic chain to enter the complex instead of the head-group. Imidazole functionalization of 
other molecules may provide a facile method of functionalizing guest molecules that do not interact 












Figure 3.6: The expanded in images of the imidazole 1H NMR peaks displaying the shielding effect 
of these peaks in the presence of the 1:1 rotaxane system showing that the cavity itself is exhibiting 
the hydrophilic effects 
In addition, we used this same guest to perform an NMR titration to investigate the association of 
the guest inside the host cavity. With the increased addition of the guest, the imidazole peaks shifted 
further towards de-shielding side showing that the polar headgroup is indeed inside the cavity of 
the γ-CD rotaxane. We did not observe the same change in the aliphatic non-polar tail end. The 
NMR titrations for 16-C ethyl imidazolium chain and the γ-CD rotaxane 1:1 showed an association 




The cavity space inside the γ-CD rotaxane is not enough to achieve 1:2 binding. This is further 
confirmed from the computational modeling seen on figure 4. 
Conclusion 
We have discovered a new efficient method of synthesizing rotaxane with ease and high yields. 
These rotaxanes can also be easily functionalized using SN2 chemistry. Furthermore, we have 
shown that these rotaxanes can be potentially used in drug delivery systems to carry small molecule 
payloads that consist of charged species. In addition, structures 3-7 can be used as a useful tool to 
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3.2 SUPPORTING INFORMATION 
 




Substrates mentioned in the supplementary information were purchased from Sigma-Aldrich, 
Fisher Scientific, and TCI chemicals. All reagents were stored under an inert atmosphere before 
use. Unless otherwise noted, all reactions were performed under N2. 
 
Instrumentation  
NMR spectra were obtained using a Bruker Avance 300 MHz and 400 MHz spectrometers. 
Low resolution mass spectrometry was performed using a Shimadzu LRMS-2020.  High 









p-Amino Benzoic Acid (2.74 g, 20.0 mmol) and 2-Aminothiophenol (2.14 ml, 20.0 mmol) were 
dissolved in (21.03 g, 250.00 mmol) polyphosphoric acid. The mixture was Heated at 200oC and 
stirred for 4.5 hours. After cooling, 10% Na2CO3 was slowly poured into solution. This resulted in 
a greenish mixture. This solution was stirred until gas evolution was completed. Next, the solution 
was filtered using vacuum filtration. The solid was washed with water (3x50mL) and recrystallized 
with MeOH and H2O to give the final product. The yield was 70%. 1H-NMR was performed using 
DMSO-d6. The literature-based procedure was followed1. LRMS ESI (m/z): [M+H] calculated for 
C13H10N2S 227.06, observed 227.05. 1H NMR (400 MHz, DMSO-d6) δ 8.02 (d, J = 8.0, 1.1 Hz, 
1H), 7.90 (d, J = 8.0 Hz, 1H), 7.76 (t, J = 8.7 Hz, 2H), 7.45 (d, J = 7.7 Hz, 1H), 7.34 (d, J = 7.7 Hz, 




















ThT-NH2 (452.6 mg, 2.00 mmol) was dissolved in 20 ml of anhydrous CH2Cl2. To this mixture 6-
Bromohexonoyl chloride (305.0 µl, 2.00 mmol) was added drop wisely. The reaction was 
performed inside a glove box under Nitrogen atmosphere. The reaction mixture was stirred 
overnight at room temperature. The reaction was monitored by TLC. After overnight stirring, the 
mixture was poured into several centrifuge tubes and centrifuged at 6000 rpm for 15 minutes. Once 
centrifugation was completed, the supernatant was discarded. CH2Cl2 was added into the remaining 
precipitate and centrifuged again. Once again, the supernatant was discarded, and this was done for 
two more times with a total of three washes with CH2Cl2. Finally, the remaining precipitate was 
dissolved in deuterated CDCl3 and centrifuged, and the precipitate was collected with the removal 
of CDCl3. (CDCl3 was used to remove the CH2Cl2 peak from the spectra.) This was subjected to 
overnight vacuum. The product was further purified using automated flash chromatography. The 
reaction yielded 59%.  1H-NMR and 13C-NMR were performed using DMSO-d6. LRMS ESI (m/z): 
[M+H] calculated for C19H19BrN2OS 403.05, observed 403.05. 1H NMR (400 MHz, DMSO-d6) δ 
10.25 (s, 1H), 8.12 (dd, J = 8.0, 1.2 Hz, 1H), 8.03 (td, J = 8.7, 7.8, 2.5 Hz, 3H), 7.80 (dd, J = 8.8, 
2.6 Hz, 2H), 7.53 (ddd, J = 8.3, 7.2, 1.3 Hz, 1H), 7.43 (ddd, J = 8.3, 7.2, 1.2 Hz, 1H), 3.64 (q, J = 
6.6 Hz, 1H), 3.55 (t, J = 6.7 Hz, 1H), 2.38 (t, J = 7.4 Hz, 2H), 1.80 (dm, J = 34.0, 7.5, 7.0, 6.8 Hz, 
2H), 1.68 – 1.58 (m, J = 7.5 Hz, 2H), 1.44 (t, J = 8.2, 7.1 Hz, 2H). 13C NMR (101 MHz, DMSO-
d6) δ 172.0, 167.5, 154.1, 142.6, 134.7, 128.5, 127.8, 127.0, 125.7, 123.0, 122.7, 119.6, 45.8, 36.8, 

























Furan protected maleimide (330.3 mg, 2.00 mmol) and ThT-6-Br (403.3 mg, 1.00 mmol) was 
dissolved in 10 mL of dry DMF. Next K2CO3 (290.2 mg, 2.10 mmol) was added and into the 
mixture. This mixture was heated to 50 ºC for overnight. The literature method only suggested 
heating for three hours, but this tends to give a mixture of starting materials and product, but letting 
it react for overnight helps to get the product exclusively. The mixture was then dissolved in 50 mL 
diethyl ether and washed with 5% HCl, followed by water to remove excess DMF. The organic 
layer was then dried with magnesium sulfate and subjected to rotatory evaporator until dryness. 
The product was further purified using automated flash chromatography. The method is given 
below. LRMS ESI (m/z): [M+H] calculated for C27H25N3O4S 488.16, observed 488.15. 1H NMR 
(300 MHz, DMSO-d6) δ 10.20 (s, 1H), 8.15 – 8.09 (m, 1H), 8.06 – 7.99 (m, 3H), 7.79 (td, J = 8.8, 
8.8, 5.4 Hz, 2H), 7.53 (ddd, J = 8.3, 7.2, 1.4 Hz, 1H), 7.43 (ddd, J = 8.4, 7.2, 1.3 Hz, 1H), 6.54 (s, 
2H), 5.12 (s, 2H), 3.36 (t, J = 7.1 Hz, 2H), 2.91 (s, 2H), 2.33 (t, J = 7.4 Hz, 2H), 1.60 (p, J = 7.5 
Hz, 2H), 1.48 (p, J = 7.2 Hz, 2H), 1.25 (p, J = 9.7, 8.9 Hz, 2H). 13C NMR (101 MHz, DMSO-d6) δ 
178.3, 176.9, 172.1, 172.1, 167.5, 162.8, 154.1, 142.6, 136.9, 134.7, 128.4, 127.7, 127.0, 125.7, 




















Synthesis of 2 
 
Maleimide (1.33g, 13.73 mmol) and furan (1.50 ml, 20.66 mmol) were dissolved in 10 mL diethyl 
ether in a sealed tube and heated to 90-100 °C for 12 hours. The 3, 6-Endoxo-Δ4- 
tetrahydrophthalhide (furan-masked maleimide) precipitated as a white solid after cooling the 
mixture to room temperature. The product was then filtered, washed with 3x10mL cold diethyl 
ether to remove the unreacted maleimide, giving rise to a yield of 6.04g (89%). The NMR spectra 
indicate that the product is exclusively the exo isomer. 1H-NMR and 13C-NMR were performed 
using DMSO-d6. LRMS ESI (m/z): [M+H] calculated for C8H7NO3 165.04, observed 165.04. 1H 
NMR (300 MHz, DMSO-d6) δ 11.15 (br, 1H), 6.52 (d, J = 0.9 Hz, 2H), 5.11 (t, J = 0.9 Hz, 2H), 




























   
 
















To a stirred solution of 2,2′-(Ethylenedioxy)bis(ethylamine) (730.0 µl, 5.00 mmol) in 25% 
MeOH/CH2Cl2 (10 mL), was added a solution of 9-anthraldehyde (2.16 g, 10.5 mmol) in 25% 
MeOH/CH2Cl2 (10 mL) under N2. The mixture was stirred at room-temperature overnight until the 
imine formation was complete (monitored by TLC). The solvent was evaporated under vacuum to 
give the crude imine product as a yellow solid, which was used for reduction without further 
purification. Reaction yield was 96%. 1H-NMR was performed using DMSO-d6. HRMS ESI (m/z): 
[M+H] calculated for C36H33N2O2 525.2542, observed 525.2485. 1H NMR (300 MHz, DMSO-d6) 
δ 9.31 (d, J = 1.4 Hz, 2H), 8.62 (s, 2H), 8.55 – 8.45 (m, 4H), 8.14 – 8.04 (m, 4H), 7.57 – 7.47 (m, 










































































































































































































































































NaBH4 (3 equiv.) was added in small portions to the solution of crude imine (1 equiv.) in 1:1 
CH3OH: CH2Cl2 (20 mL) at 0°C. The mixture was stirred at room temperature overnight, then 
concentrated under vacuum. The residue was dissolved in CH2Cl2 (50 mL) and washed three times 
with 50mLof aqueous Na2CO3 (pH=10). The organic layer was separated, dried over anhydrous 
Na2SO4, filtered, and concentrated under vacuum to provide the secondary amines. Reaction yield 
was 90%. 1H-NMR and 13C-NMR were performed using DMSO-d6. HRMS ESI (m/z): [M+H] 
calculated for C36H36N2O2 529.2855, observed 529.2794. 1H NMR (300 MHz, DMSO-d6) δ 8.50 
(s, 2H), 8.40 – 8.31 (m, 4H), 8.05 (dd, J = 7.7, 2.0 Hz, 4H), 7.55 – 7.44 (m, 8H), 4.58 (s, 4H), 3.49 
(t, J = 5.6 Hz, 8H), 2.82 (t, J = 5.6 Hz, 4H), 2.03 (br, 2H). 13C NMR (101 MHz, DMSO-d6) δ 135.0, 





















































































































































































































































































8 (2.2 equiv.) and 4 (1 equiv.) was mixed in 20 ml of Toluene. This reaction mixture was refluxed 
at 110oC for overnight. Physical observation of the formation of Diels-alder adduct was observed 
by the change of colors from yellow solution to white with precipitate. Next, the reaction mixture 
was subjected for rotary evaporation until dryness and dried overnight under high vacuum. 
Reaction yield was 45%. 1H-NMR and 13C-NMR were performed using DMSO-d6. HRMS ESI 
(m/z): [M+H] calculated for C44H46N4O6 723.3081, observed 723.3083. 1H NMR (400 MHz, 
DMSO-d6) δ 10.68 (br, 2H), 7.50 (dd, J = 7.3, 1.5 Hz, 2H), 7.42 (dd, J = 6.9, 1.7 Hz, 2H), 7.25 
(ddd, J = 7.0, 4.0, 1.9 Hz, 5H), 7.13 (dddt, J = 12.6, 8.7, 5.1, 1.5 Hz, 9H), 4.65 (d, J = 3.3 Hz, 2H), 
3.95 (d, J = 12.3 Hz, 2H), 3.76 (d, J = 12.3 Hz, 2H), 3.66 (d, J = 6.3 Hz, 7H), 3.28 (dd, J = 8.7, 3.1 
Hz, 2H), 3.24 – 3.20 (m, 2H), 3.09 – 2.95 (m, 4H), 2.30 (s, 2H), 1.95 (br, 2H). 13C NMR (101 MHz, 
DMSO-d6) δ 178.4, 177.9, 143.5, 141.2, 140.4, 129.4, 128.7, 126.8, 126.6, 126.3, 125.2, 124.3, 






























γ-CD (1 equiv.) and 4 (1 equiv.) was mixed in 20 ml of Toluene. This reaction mixture was 
ultrasonicated for 15 minutes. Then it was heated at 80oC for another 15 minutes. To this solution 
8 (2.4 equiv.) was added and the complete reaction mixture was refluxed at 110oC for overnight. 
Physical observation of the formation of Diels-alder adduct was observed by the change of colors 
from yellow solution to white with precipitate. Next, the reaction mixture was subjected for rotary 
evaporation until dryness and dried overnight under high vacuum. By changing the addition 
equivalents to 1 or 2 of the γ-CD, it was possible to obtain 1 or 2 CDs on the thread. Reaction yield 
was 90%, 89% and 83% in the order of 1:1, 1:2 and 2:1. 1H-NMR, 13C-NMR and ROESY NMR 












































Figure 3.34: mass spectrum 4 at the range of 1655-1668 m/z 
 
Figure 3.35: Complete mass spectrum of 5 
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β-CD (1 equiv.) and 4 (1 equiv.) was mixed in 20 ml of Toluene. This reaction mixture was 
ultrasonicated for 15 minutes. Then it was heated at 80oC for another 15 minutes. To this solution 
8 (2.4 equiv.) was added, and the complete reaction mixture was refluxed at 110oC for overnight. 
Physical observation of the formation of Diels-alder adduct was observed by the change of colors 
from yellow solution to white with precipitate. Next, the reaction mixture was subjected for rotary 
evaporation until dryness and dried overnight under high vacuum. By changing the addition 
equivalents to 1 or 2 of the β-CD, it was possible to obtain 1 or 2 CDs on the thread, resulting 1:2 
and 2:1 rotaxanes. Reaction yield was 91%, 92%, 94% in the order of 1:1, 1:2 and 2:1. 1H-NMR, 









































































































































Figure 3.56: mass spectrum of 7 at the range of 1475 - 1540 m/z 















































Synthesis of 10 and 11
 
γ-CD (1 equiv.) and 4 (1.1 equiv.) was mixed in 20 ml of Toluene. This reaction mixture was 
ultrasonicated for 15 minutes. Then it was heated at 80oC for another 15 minutes. To this solution 
8 (2.4 equiv.) was added the complete reaction mixture was refluxed at 110oC for overnight. 
Physical observation of the formation of Diels-alder adduct was observed by the change of colors 
from yellow solution to white with precipitate. Next, the reaction mixture was subjected for rotary 
evaporation until dryness and dried overnight under high vacuum. By changing the addition 
equivalents to 1 or 2 of the γ-CD, it was possible to obtain 1 or 2 CDs on the thread. Reaction yield 





















Figure 3.64: mass spectrum of 10 
 






NMR titration of 1 and γ-CD 
The NMR titration experiments were conducted per the following procedures.2 The host CD 
concentrations were kept constant while the guest concentration was increased periodically. Stock 
solutions of 20 mM host (cyclodextrin) and 60 mM guest were prepared. A series of NMR samples 
were made in 5 mm NMR tubes. The series ranged from 10 mM to 80 mM. All samples were 
prepared and heated for 3 minutes at 80 oC and cooled to room temperature. The NMR was 
performed at 300K (Room temperature). The guest protons were monitored. Data was processed 
using an Excel spreadsheet using the equation shown below and fitting the data. The plots are 
shown below. The data was evaluated using the “OpenDataFit” website which is an online free 
fitting program found at supramolecular.org.2 The two different analysis methods provided similar 
results. 




) + {[𝐻0] + [𝐺0] +
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)2 − 4[𝐻0] [𝐺0])
1
2} 
where ∆δ = change in chemical shift, [H0] = Initial Host concentration, [G0] = Initial concentration, 































Computational studies were performed using commercially available Spartan 16 and Molecular 
operating environment (MOE) software. Spartan was used to design the supramolecular 
compounds in 3D space. Energy minimizations, dynamics and docking were performed using 
MOE. Energy minimizations were conducted using the MMFX94 force field,20 with an R-field of 
1.80. A unit cell was created around the molecule with a cell size of 43.321 Å in x, y, z directions. 
The periodic system was used to perform the calculations. Rigid water molecules were chosen, 
with a gradient of 0.001 RMS kcal/mol/Å.02 
The energy minimized structure was prepared for docking by using the built-in prep tool named as 
“quick-prep.” This tool fixes errors present in the molecule such as adding missing hydrogens and 
charges. This molecule was further subjected to molecular simulations via NPA (Nose-Poincare-
Anderson equation) method21, which is the most correct and most sensitive method used by the 
MOE software. All simulations were performed inside the unit cell, with water surrounding water 
molecules at a temperature of 300K. 
The guest was manually selected to dock the guest inside the CD cavity. This made the CD as the 
host receptor. The site finder tool was used to place dummy atoms inside the hydrophobic cavity 
of the CD. This was done to optimize the docking procedure. The unit cell mentioned above was 
maintained with its initial parameters at the docking stage to mimic the solvent effect. Triangle 
matcher was used as the docking placement methodology while London dG was selected as the 
initial scoring methodology. A number of 50 poses were passed to the refinement step. Rigid 
receptor post-placement refinement was used with GBVI/WSA as the final scoring method. The 
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The synthesized novel Thioflavin-appended pillararene structure can switch from a folded, 
intercalated form to an open form via a change of temperature or in response to a chemical analyte. 
This unique behavior was studied using 1D and 2D NMR spectroscopy, fluorescence spectroscopy, 
and computational modeling. In synthesizing the novel structure, new reaction conditions with 
higher yields for the synthesis and functionalization of copillararenes were developed.  The dual-
functionalized pillararene is a unique molecular switch that can be used to bind analyts in it 





Despite the relatively short time since their discovery, pillararenes have been widely used 
in applications ranging from molecular machines1 to drug delivery.2  These barrel-shaped 
macrocyclic structures were first reported by Ogoshi and coworkers.3 When compared with other 
supramolecular structures, pillararenes are far more versatile and robust due to their ease of 
functionalization and synthesis.4 Our group became interested in the chemistry of pillararenes as 
part of our efforts to design and discover molecular structures that are capable of binding xenon,5 
which can be used as molecular contrast agents for 129Xe MRI.6 During the course of these studies 
we have optimized the conditions by which co-pillararenes (Co-P5A) can be synthesized and 
functionalized.  Herein, we report these synthetic advances and their application to the development 




Results and discussion 
The synthesis of the Co-P5A commenced using monomers containing bromoethyl and 
propargyl groups (1 and 2).  These two monomers were mixed in a series stoichiometries and Lewis 
acids. Numerous co-P5A syntheses have been published using an excess of the brominated 
monomer, usually 10:1,10 but in our hands, the yield for the Co-P5A increased 10-fold when the 
ratio was lowered to 5:1. The only side product that we obtained was the per-brominated P5A (See 
Supporting Information for details).  
Subsequent functionalization of 3 via copper-catalyzed azide-alkyne cycloaddition also 
proved to be unfruitful by a variety of common reaction conditions.  Molecular modeling indicated 
that the barrel-shaped structure of 3 was closed on the top and bottom, as the flexible bromyethyl 
and propargyl appendages bent towards the hydrophobic cores.  We hypothesized that the insertion 
of a guest molecule into the macrocycle could force the propargyl group into a solvent-exposed 
position.  This hypothesis was supported by computational modelling and was verified 
experimentally.   Simply switching the solvent from tert-butanol or dichloromethane to 1,2-
dichloroethane, a solvent that is known to fit into the inner core of pillararene structures, increased 
the yield of the cycloaddition from 0% to 80% (Scheme 4-1). 
 
Figure 4.1: Optimized synthesis of functionalized co-pillararenes.  (Molecular modeling images 
with propargyl group highlighted.) 
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We chose to append two thioflavin T (ThT) molecules to the P5A core using a flexible six-
carbon linker.  ThT is a fluorescent dye that is widely used for its ability to bind the -amyloid 
plaques that are associated with Alzheimer’s disease.  However, the properties that were the most 
essential for the design of our molecular switch were ThT’s linear structure and its fluorescent 
properties.  Following the synthesis of the difunctionalized pillararene, 5, we observed that formed 
a unique self-inclusion structure, where one of the pendant ThT-terminated “arms” was threaded 
through the core of the P5A (Figure 4-1) 
 
Figure 4.2: Cartoon representation of the self-inclusion behavior with the change of conditions 
The inclusion behavior of ThT-pillararene was first studied via 1H NMR spectroscopy in different 
solvents (Figures 4.4). In the 1H NMR spectra, the unique upfield chemical shifts between -0.5 and 
-2.5 ppm correponds to the protons in the linker arm group connecting the ThT linker to the 
pillararene (Light blue region). This indicates the inclusion of the linker connected to the ThT group 
into the cavity of the P5A, which resulted in the formation of the inclusion structure ThT-CoP5A. 
Similar upfield shift phenomena were also observed from the spectrum using acetone-d6 as the 
solvent. However, the signals of the protons of ThT-pillararene in 1H NMR spectra was in the 
positive chemical shift range in strong polar solvents, such as DMSO-d6, which meant that the 
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inclusion behavior of ThT-CoP5A was destroyed in DMSO-d6. This type of behavior has been 
previously shown by Wu and his co-workers9.  
This was further investigated using the molecular dynamics studies using MOE 
computational software. Firstly a flexible assignment scan was conducted to find out if molecular 
dynamics could result in a structure with a self-inclusion. The scan gave us a flexible assignment 
showing the self-inclusion assignment. Next, a unit cell was created to accommodate the self-
inclusion complex in the inclusion stage and DMSO-d6 was used as a solvent, and multiple 
molecular dynamic iterations were carried out. From the results, it was evident that DMSO-d6 
pushes the ThT and the linker arm due to binding of DMSO inside the P5A cavity. The same control 
study was performed using the CDCl3 as the solvent, the inclusion remains inside with no release 












Figure 4.3: L to R, ThT Co-P5A in a simulated environment surrounded with CHCl3 molecules 
(Self-inclusion form), ThT Co-P5A in a simulated environment surrounded with DMSO molecules 
(Free-form) 
To investigate whether the inclusion behavior was intramolecular or intermolecular, host-
guest interaction between just the ThT azido linker and Co-P5A was firstly studied by themselves. 
This experiment was used as a control study to show the unique self-inclusion behavior present in 
the product itself.  As shown in Figure S4.48 and S4.49 in the supplementary information, the 1H 
NMR spectra of Co-P5A with the addition of different equivalents of ThT azido linker showed that 
the chemical shifts of the linker arm gradually shifted upfield with the increase of the ThT azido 
linker, exhibiting a fast exchange process within the NMR timescale. The most visible observation 
from this titration is that with the addition the chemical shifts corresponding to the linear arms 
became broader, which suggests that binding does take place. This broadening is not seen in the 
aromatic range of the linker, indicating that the linker arm protons do indeed bind in the cavity of 
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the Co-P5A. The linker arm protons have five distinguishable peak areas which range from ppm of 
3.27, 2.38, 1.75, 1.62  and 1.44. These chemical shifts were then moved up field with the addition 
of ThT linker to ppm ranges of 3.11, 2.32, 1.66, 1.522 and 1.39. This means that there is only a 
slightly upfield shift around 0.16 ppm of these linker arm protons.  
 




Figure 4.5: Temperature study of 1H-NMR of ThT-CoP5A in CDCl3 
As the concentration increased, the proton resonances did not exhibit apparent changes 
even at high concentration levels of 500 mM, which almost reaches the saturation level of the ThT 
linker. As a result, the interaction between ThT azido linker and Co-P5A was weak. This confirms 
that the ThT-CoP5A molecule is indeed occurred due to intramolecular forces, this further 
confirmed that with the increase in ThT azido linker no negative chemical shift peaks were 
observed (seen when the self-inclusion takes place). 
Moreover, variable concentration 1H NMR spectroscopy of ThT-CoP5A in CDCl3 was 
carried out to monitor the stability of the self-inclusion complex. It was found that the aggregates 
formed by ThT-CoP5A were stable even in very dilute CDCl3 solution (1 mM) and still showed 
the negative chemical shifts. This points out that these interactions that are formed are strong and 
stable.  
In addition, we conducted a variable temperature 1H NMR spectroscopy. This was 
conducted to show that with heat the self-inclusion complex unwraps to form the free form. As 
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seen in figure 6, where the up-field peaks which were showing three doublets start to disappear 
slowly and the peaks of the spectra become sharper showing the release of the ThT-linker arm. 
However, we can still see that the up-field peaks do not disappear even after heating to 60 °C 
showing that a specific population of the Self-inclusion complexes still exists. Also, we reversed 
the temperature letting the sample gradually cool down, to show that the final product does not 
undergo decomposition at an elevated temperature (60 °C). This shows the stability under varying 
temperatures. The stability at 30 – 40 °C is important, allowing us to use the ability of self-inclusion 
of this molecule in a biological system. 
1H NMR COSY, ROESY, and TOCSY experiments were performed to investigate the 
binding of the linker arm further and show that one of the linker arms exists in the free form and 
the other stays at the self-inclusion form. The ROESY data shows that these movements are taking 
place in equilibrium in liquid form. The diagonal peaks (light green box) at the negative chemical 
shifts corresponds to the linker arm protons that are inside the cavity of the P5A, while the peaks 
below (light blue box) those represents the other linker arm protons that are outside the cavity. 
Presence of these two different sets of signals for the same linker arms implies that these protons 
are in chemical exchange. 
Furthermore, these outside protons have direct ROE correlations with 1.85, 1.55 and 1.19 
chemical shift peaks which confirms that these are the linker arm protons that is situated outside 
the cavity of P5A. Also, the negative peaks at -1.37 and -0.66 show ROE correlations to the 
aromatics of the P5A. Similar ROE peaks are seen from the negative chemical shifts to the 
methylene groups of P5A structure. Also, through TOCSY studies we were able to pinpoint the 
directionality of the linker arm bound to the cavity with respect to its chemical shifts -1.18, -2.38, 
-3.62, -3.25, -1.64 and -0.87 ppm. This pattern points out that the highest upfield chemical shifts 
are from the protons that are fully encapsulated within the cavity, while the others are exposed 
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Figure 4.6: ROESY spectrum of ThT Co-P5A in CDCl3 
Subsequently, we attempted to investigate the dynamic behavior of this self-assembled ThT Co-
P5A. As mentioned earlier, the effect of solvent polarity on this disassembly process was 
investigated. It was found that, with the increase of the solvent polarity by gradually adding DMSO-
d6 or 1,2-dichloroethane into the CDCl3 solution of ThT-CoP5A, the negative chemical shifts for 
the linker arm present in th self-inclusion structure disappeared gradually. This observation 
suggested that the self-inclusion structure was gradually destroyed, presenting a slow exchange 
process within the NMR timescale. When the ratio of the mixture DMSO-d6/CDCl3 was raised to 
1: 1 (v/v), most of the self-inclusion structure was switched into the free form. This was shown to 
be true to both solvents DMSO and 1,2-DCE (See supporting info for spectra).  
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Next, we studied competitive binding using fluorescence as shown in figure 6. ThT moieties are 
known to be fluorescent. Hence the overall molecule has a moderate fluorescence activity. This can 
be used to show the unwinding of the linker. Furthermore, we performed another titration 
experiment that refers to the addition of DMSO into the self-assembled structure in CDCl3 to 
observe any changes in the fluorescence emission, due to the thioflavin moieties on the CoP5A 
results in fluorescence emission. This led to us to observe an increase in fluorescence emission with 
an addition of DMSO. As seen on the figure with the addition of the DMSO, a new band at 385 nm 
appeared which was not observed when no DMSO was present. We hypothesize that this new 
fluorescence signal corresponds to the open non-included complex. 
 
Figure 4.7: Fluorescence emission spectra of ThT self-assembled CoP5A, with the addition of 
DMSO. The excitation wavelength used was 304 nm 
Furthermore, it is known that P5A has the tendency to bind small organic compounds such 
as adiponitrile inside its hydrophobic cavity.  We gradually titrated this linear guest into a solution 
of ThT-CoP5A in CDCl3 (the self-included complex).  As soon as the guest was added, a new broad 
upfield peak started to form , corresponding to included adiponitrile, and the  self-inclusion peaks 





Figure 4.8: Stacked 1H NMR of the non-water soluble and water-soluble ThT CoP5A 
Once the self-inclusion phenomena were fully investigated, we focused on synthesizing a 
water-soluble version of the ThT-CoP5A (Figure 4.8). This was achieved by adding Me3N and 
heating at 100 °C for 48 hours. Surprisingly, once the bromide groups are converted to ammonium 
ions, no inclusion phenomena were observed. This could be attributed to steric hindrance to the 
upper and lowers rims of the pillararene, but it could also simple be the consequence of the aqueous 
solvent, as we have previously shown that the polarity and size of the solvent can switch the ThT-





Figure 4.9: Titration of Adiponitrile in to ThT-CoP5A in CDCl3 at 298K, the boxes show zoomed 
images of the area, except red box indicates the binding of adiponitrile in the cavity of the ThT Co-
P5ATitration of Adiponitrile in to ThT-CoP5A in CDCl3 at 298K, the boxes show zoomed images 






We have successfully synthesized a novel switchable pillar[5]arene structure that can be switched 
from closed to open with temperature and polar solvents. This switchable pillar[5]arene can be used 
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4.2 SUPPORTING INFORMATION 
 




Substrates, hydroquinone, boron trifluoride etherate, 1,2 dichloroethane, dichloromethane, 
DMF, sodium azide, CuSO4. 5H2O, sodium ascorbate, tri methyl amine, CBr4, methanol, 
acetonitrile, 
were purchased from Sigma-Aldrich, Fisher Scientific, and TCI chemicals. All reagents 
were stored under an inert atmosphere before use. Unless otherwise noted, all reactions 
were performed under N2. 
Instrumentation  
NMR spectra were obtained using a Bruker Avance 300 MHz and 400 MHz spectrometers. 
Low-resolution mass spectrometry was performed using a Shimadzu LRMS-2020. High-
resolution mass spectrometry was performed using a Thermo Scientific LTQ Orbitrap 
XL™ instrument. Isothermal calorimetry was performed using TA Instruments TAM III™ 










Synthesis of Brominated monomer 
 
A solution of 1,4-bis(2-hydroxyethyl)benzene (10.0 g, 50.4 mmol) and triphenylphosphine 
(31.5 g, 120mmol) in dry acetonitrile (250 mL) was cooled in an ice bath. While vigorous 
stirring, carbon tetrabromide (39.8 g, 120 mmol) was slowly added in four portions. In 
every addition, the solution immediately turns in to bright yellow and with futher stirring 
returns to its colorless form. On the final addition, the solution stays cloudy. The mixture 
was stirred at room temperature for 4 hours and 20 minutes. Then cold water (200 mL) was 
added to the reaction mixture to give white precipitation. This collected precipitate was 
washed with another 200 ml of cold water and  methanol/water wash. (3:2, 3 × 100 mL). 
The collected white solids were dried under vacuum for 24 hours and used without further 
purification. (14.5 g, 97%). 1H NMR and 13C NMR were performed using CDCl3. 1H NMR 
(400 MHz, Chloroform-d) δ 6.89 (s, 4H), 4.27 (t, J = 6.3 Hz, 4H), 3.64 (t, J = 6.3 Hz, 4H). 












Figure 4.11: 13C-NMR of Brominated monomer 
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Synthesis of proapargylated monomer 
 
 
Hydroquinone, anhydrous potassium carbonate was added into solution of acetonitrile. 
Then the reaction mixture containing RBF was placed on an ice bath. Next, the propargyl 
bromide was added in drop wisely. Then, the reaction solution was stirred 20 hours at 60 
°C. Once the reaction was completed, the solvent was removed via rotary evaporation. 
Dichloromethane (100 ml) was added into the RBF, and this was transferred into a 
separatory funnel for further washes. Washing steps were conducted using 2.5 M NaOH (3 
x 100 ml) followed with DI water (3 x 100 ml) and finally with brine (2 x 100 ml). Then 
the DCM layer was collected and dried over anhydrous sodium sulfate. The final mixture 
was subjected to dry loaded automated flash chromatography. 1H NMR and 13C NMR were 
performed using CDCl3. 1H NMR (400 MHz, DMSO-d6) δ 6.95 (s, 4H), 4.74 (d, J = 2.5 











Synthesis of Co-pillar[5]arene 
 
Brominated monomer, proapargylated monomer, and paraformaldehyde were added into 
an RBF charged with 1,2-dichloroethane. Next, the boron trifluoride etherate was added in 
dropwise at room temperature. The reaction mixture was left to stir at room temperature 
for 30 minutes. Subsequently, 20 ml of methanol was added after the 30 minutes to quench 
the reaction. The resulting solution was evaporated using the rotary evaporator. To the 
dried mixture, 20 ml of DCM was added, which was then transferred into a separatory 
funnel for further washing. Washing steps were conducted using 10% (m/v) sodium 
bicarbonate (2 x 10 ml) which was followed with 10 ml DI water wash. The collected DCM 
layer was evaporated and the directly subjected into dry loaded automated flash 
chromatography. 1H NMR and 13C NMR were performed using CDCl3. 1H NMR (400 
MHz, Chloroform-d) δ 6.84 (s, 2H), 6.81 – 6.77 (m, 6H), 6.69 (s, 2H), 4.51 (d, J = 2.4 Hz, 
4H), 4.18 – 4.05 (m, 17H), 3.80 – 3.73 (m, 10H), 3.53 (dtd, J = 21.0, 5.7, 2.3 Hz, 17H), 
2.13 (t, J = 2.4 Hz, 2H). 13C NMR (101 MHz, Chloroform-d) δ 149.73, 149.70, 149.6, 
149.3, 129.4, 129.1, 129.0, 128.9, 116.2, 116.1, 115.9, 115.8, 115.6, 79.2, 74.9, 69.1, 69.1, 










Table 4-1: The data represents the yields that were obtained with the change of the brominated 




















Figure 4.13: Top: the flash chromatogram of the 1:10 equivalents in hexane/dichloromethane 
solvent system. Peaks correspond to products that were recovered. Bottom: flash chromatogram of 
the 1:5 equivalents in hexane/dichloromethane solvent system  
Ratio was changed from 1:10 to 



























p-Amino Benzoic Acid (2.74 g, 20.0 mmol) and 2-Aminothiophenol (2.14 ml, 20.0 mmol) was 
dissolved in (21.03 g, 250.00 mmol) polyphosphoric acid. The mixture was heated at 200oC and 
stirred for 4.5 hours. After cooling, 10% Na2CO3 was slowly poured into solution. This resulted in 
a greenish mixture. This solution was stirred until gas evolution was completed. Next, the solution 
was filtered using vacuum filtration. The solid was washed with water (3x50mL) and recrystallized 
with MeOH and H2O to give the final product. The yield was 70%. 1H-NMR was performed using 
DMSO-d6. Literature-based procedure was followed1. LRMS ESI (m/z): [M+H] calculated for 
C13H10N2S 227.06, observed 227.05. 1H NMR and 13C NMR were performed using DMSO-d6. 1H 
NMR (400 MHz, DMSO-d6) δ 8.02 (d, J = 8.0, 1.1 Hz, 1H), 7.90 (d, J = 8.0 Hz, 1H), 7.76 (t, J = 




















ThT-NH2 (452.6 mg, 2.00 mmol) was dissolved in 20 ml of anhydrous CH2Cl2. To this mixture 6-
Bromohexonoyl chloride (305.0 µl, 2.00 mmol) was added drop wisely. The reaction was 
performed inside the glove box with a Nitrogen atmosphere. The reaction mixture was stirred 
overnight at room temperature. The reaction was monitored by TLC. After overnight stirring the 
mixture was poured into several centrifuge tubes and centrifuged for 15 minutes at 6000 rpm. Once 
centrifugation was completed, the supernatant was discarded. CH2Cl2 was added into the remaining 
precipitate and centrifuged again. Once again, the supernatant was discarded, and this was done for 
two more times with a total of three washes with CH2Cl2. Finally, the remaining precipitate was 
dissolved in deuterated CDCl3 and centrifuged, and the precipitate was collected with the removal 
of CDCl3. (CDCl3 was used to remove the CH2Cl2 peak from the spectra.) This was subjected to 
overnight vacuum. The product was further purified using automated flash chromatography. The 
reaction yielded 59%.  1H-NMR and 13C-NMR were performed using DMSO-d6. 1H NMR (400 
MHz, DMSO-d6) δ 10.25 (s, 1H), 8.12 (dd, J = 8.0, 1.2 Hz, 1H), 8.03 (td, J = 8.7, 7.8, 2.5 Hz, 3H), 
7.80 (dd, J = 8.8, 2.6 Hz, 2H), 7.53 (ddd, J = 8.3, 7.2, 1.3 Hz, 1H), 7.43 (ddd, J = 8.3, 7.2, 1.2 Hz, 
1H), 3.64 (q, J = 6.6 Hz, 1H), 3.55 (t, J = 6.7 Hz, 1H), 2.38 (t, J = 7.4 Hz, 2H), 1.80 (dm, J = 34.0, 
7.5, 7.0, 6.8 Hz, 2H), 1.68 – 1.58 (m, J = 7.5 Hz, 2H), 1.44 (t, J = 8.2, 7.1 Hz, 2H).LRMS ESI 













Synthesis of Thioflavin-6-azide 
 
 
ThT-6-Br (1 equiv.) was dissolved in anhydrous DMF 30 ml and to this solution Sodium 
azide (4 equiv.) was added. This reaction mixture was stirred at 80 °C for 12 hours. The 
resulted reaction mixture was quenched by adding 150 ml of DI water and the extraction 
with ethyl acetate (3 x 100ml). The collected organic layer was dried over anhydrous 
sodium sulfate and subjected to dry loaded automated flash chromatography. 1H NMR was 
performed using DMSO-d6. 1H NMR (300 MHz, DMSO-d6) δ 10.23 (s, 1H), 8.16 – 8.11 
(m, 1H), 8.08 – 8.01 (m, 3H), 7.84 – 7.78 (m, 2H), 7.54 (ddd, J = 8.3, 7.2, 1.4 Hz, 1H), 
7.44 (ddd, J = 8.3, 7.2, 1.3 Hz, 1H), 3.37 (t, J = 6.8 Hz, 2H), 2.38 (t, J = 7.3 Hz, 2H), 1.60 
(dq, J = 18.5, 7.2 Hz, 4H), 1.46 – 1.32 (m, 2H). 13C NMR (101 MHz, DMSO-d6) δ 172.1, 













Figure 4.22: Mass spectrum of Thioflavin-6-azide linker  
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Synthesis of ThT-CoP5A 
 
Co-P5A (46.3 mg) , ThT-6N3 (23.8 mg), CuSO4.5H2O (25.0 mg) and L-ascorbic acid 
(20.1 mg) was added in to a 10 ml microwave vial, to this vial 2 ml of 1,2-DCE was added 
in, which was followed up with 2 ml of ultra-pure water. Next this reaction mixture was 
subjected to 300 W microwave power at 70 °C for 1 hour in a microwave with stirring. The 
resulting mixture was the transferred in to a separatory funnel. DI water 10 ml was added 
in to the same funnel and extraction was performed with 3 x 10 ml DCM. The collected 
DCM layer was dried over anhydrous sodium sulfate and subjected to dry loaded 
automated flash chromatography for purification. 1H NMR and 13C NMR was performed 
using DMSO-d6 and CDCl3. 1H NMR (400 MHz, DMSO-d6) δ 10.21 (s, 2H), 8.27 (s, 2H), 
8.11 (dd, J = 8.0, 1.1 Hz, 2H), 8.06 – 7.95 (m, 6H), 7.84 – 7.75 (m, 4H), 7.53 (ddd, J = 8.2, 
7.2, 1.3 Hz, 2H), 7.47 – 7.39 (m, 2H), 7.09 (s, 2H), 7.01 – 6.90 (m, 6H), 6.83 (s, 2H), 5.18 
(d, J = 11.3 Hz, 2H), 4.95 (d, J = 11.1 Hz, 2H), 4.44 (q, J = 8.0, 7.5 Hz, 9H), 4.30 – 4.19 
(m, 3H), 4.09 (dq, J = 11.5, 5.7 Hz, 10H), 3.88 – 3.74 (m, 21H), 2.38 (t, J = 7.3 Hz, 4H), 
1.92 (p, J = 7.1 Hz, 4H), 1.69 (p, J = 7.4 Hz, 4H), 1.36 (p, J = 7.8 Hz, 4H).  13C NMR (101 
MHz, DMSO-d6) δ 171.9, 167.5, 154.1, 149.4, 149.3, 149.3, 143.6, 142.6, 134.7, 129.0, 
128.9, 128.7, 128.7, 128.4, 127.8, 127.0, 125.6, 124.4, 123.0, 122.7, 119.6, 115.6, 115.1, 





















Table 4-2: Various click reaction conditions that were used during the screening process of 




   
 
 
















































Synthesis of water soluble ThT Co-P5A 
 
ThT-CoP5A (143. 2 mg) was mixed with tri methylamine (250 ul) to this 1 ml CHCl3 and 
2 ml ethanol was added. All these was added into a pressure tube. This reaction mixture 
was then heated at 100 °C for 48 hours with stirring. After the 48 hours, the reaction 
mixture was cooled to room temperature, and the solvent was evaporated. To the dried 
mixture, 5 ml of ultra-pure water was added, and any resulting precipitate was filtered using 
Whatman 40 filter paper. The final filtered solution was cooled in a -20 °C refrigerator and 
then freeze-dried to obtain the final dried product. 1H NMR and 13C NMR were performed 
using DMSO-d6. 1H NMR (400 MHz, DMSO-d6) δ 10.61 (s, 2H), 8.42 (s, 2H), 8.15 – 8.09 
(m, 2H), 8.05 – 7.98 (m, 6H), 7.91 – 7.84 (m, 4H), 7.53 (ddd, J = 8.3, 7.2, 1.3 Hz, 2H), 
7.44 (ddd, J = 8.3, 7.2, 1.2 Hz, 2H), 7.14 – 6.89 (m, 10H), 5.20 – 5.04 (m, 4H), 4.75 – 4.35 
(m, 20H), 4.08 (d, J = 47.9 Hz, 19H), 3.72 (d, J = 38.1 Hz, 11H), 3.23 (s, 87H), 2.42 (t, J = 
7.3 Hz, 4H), 1.89 (p, J = 7.2 Hz, 4H), 1.67 (p, J = 7.6 Hz, 4H), 1.32 (p, 4H). 13C NMR (101 
MHz, DMSO-d6) δ 172.2, 167.5, 154.1, 149.5, 149.3, 142.7, 134.7, 128.7, 128.4, 127.7, 
127.1, 125.7, 123.0, 122.7, 119.6, 57.8, 54.9, 54.8, 54.8, 53.6, 53.5, 49.8, 44.4, 36.6, 34.6, 














































Figure 4.38: SEM images, as indicated from the arrows each one represents the increase of the 
level of magnification and decrease of the particle size ranging from 100 µm to 200 nm. The yellow 
boxes indicate the area that was zoomed in. The sample was loaded on to a platform and then it 
was gold spluttered. This gold spluttered surface was used to observe the surface in its dried form 













































































































































Figure 4.53: Computational model after molecular dynamics in DMSO solvent system. (Space 
filling model)  
290 
 
5 CHAPTER 5 
 
Will be submitted to Supramolecular chemistry 
 
 
Cationic Pillararenes: Porous Single Molecules for Binding Toxicants in Aqueous Media 
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The ability to detect biologically relevant small molecules with high levels of selectivity, sensitivity 
and broad applicability for a variety of analytes in a variety of complex environments is an essential 
goal in bioanalytical chemistry. Methods to achieve such detection vary widely and include the use 
of electrochemical, spectroscopic, and visible read-out signals. The purpose of supramolecular 
chemistry to accomplish such detection has many notable advantages, including straightforward 
tunability, high general applicability, and ease of modification of every component. Reported 
herein is the use of supramolecular chemistry of pillar[5]arenes to accomplish precisely such 
detection. A variety of pillar[5]arenes has been synthesized and analyzed for their applicability 
toward small molecule detection schemes. Water-soluble pillar[5]arenes functionalized with 
cationic linker arms have been found to bind small molecule toxicants in their hydrophobic cavities 
with association constants on the orders of 105 and 106 M-1. With the use of exchange resins, 
cationic pillar[5]arenes could be removed from solution along with their encapsulated guests, 





The development of methods for the selective removal of highly toxic organic pollutants from 
aqueous environments is a pressing research need with significant implications in public health,1 
environmental legislation,2 and biological sciences.3,4 Many existing methods for such removal 
suffer from significant drawbacks, including lack of selectivity in toxicant removal,5 introduction 
of toxic removal agents in order to remove the targeted pollutants,6 inefficient toxicant removal 
performance,7 and lack of recyclability of the removal agents.8 These drawbacks are particularly 
significant for compounds that are highly environmentally persistent, which means that such 
compounds will remain in the environment for several years after an initial contamination event 
unless actively removed, as well as for compounds that lack clear detectable signatures,9 including 
visible colour and/or high luminescence, which means that their continued presence in the 
environment is challenging to detect. 
Previous work from our research groups has reported extensive results using cyclodextrin-based 
systems for highly effective toxicant detection and medical imaging applications.10,11,12 Some work 
in synthetically-modified cyclodextrins,13-15modified curcubiturils,16 and fully synthetic all-organic 
macrocycles17,18 has also been reported, but the utility of such materials in small molecule binding 
and sequestration has not been fully explored. The highly efficient removal of micropollutants 
using insoluble cyclodextrin polymers cross-linked with rigid aromatic groups has been reported 
by Dichtel and co-workers.19,20 While this material was highly effective at pollutant capture in both 
air and water,21 it required anhydrous conditions and a multi-day reaction time to synthesize the 
porous polymer in 45% isolated yield. Moreover, the use of an insoluble material for pollutant 
removal rather than the soluble macrocycle reported herein comes with additional trade-offs in 
terms of detailed material characterization, as well as rationally-guided opportunities for further 
tunability and structural optimization. 
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Compared to cyclodextrin-based systems, pillararenes are relatively new, with the first reported 
pillararene synthesized by Ogoshi and co-workers in 2008.22 These macrocycles, which are formed 
from the condensation reaction of a 1,4-dialkoxybenzene with paraformaldehyde, and generally 
form the thermodynamically favored 5-membered cyclic oligomer, termed a pillar[5]arene,23 
having symmetrical, rigid, pillar-like cavities,24 The electronic and steric properties of pillararenes 
can be tuned via judicious choice of dialkylhydroquinone starting material, although overall highly 
electron-rich structures are obtained.25 As a result, pillar[5]arenes are well-suited to bind electron 
deficient small molecule guests in their interior cavities,26 with binding constants between 103 and 
105 M-1 generally obtained.27 Examples of small molecule guests include biologically relevant 
analytes such as methionine,28 tryptophan,29 and adenosine triphosphate (ATP),30 with the 
pillararenes in those cases bearing cationic groups that facilitate aqueous solubility.  
Despite the significant advances in pillararene syntheses and applications that have been 
reported in recent years, the use of pillararenes for environmental remediation applications such as 
purification of contaminated water has been only rarely reported. This is true despite the fact that 
pillararene-induced binding of environmentally relevant analytes has strong potential to facilitate 
such environmental remediation, provided that there is a mechanism to remove the analytes of 
interest after binding in the pillararene is achieved. Such analytes include polycyclic aromatic 
hydrocarbons (PAHs),31 polyfluorooctanoic acid (PFOA),32 aromatic pesticides,33 pharmaceutical 
drugs such as Tylenol and Advil,34 and plasticizers such as phthalate esters,35 all of which have 
been found in aqueous environments and have the potential to induce deleterious health effects.36 
Reported herein is the use of a newly synthesized cationic pillar[5]arene to bind a broad 
variety of small molecule organic analytes, including several of the analytes listed above, with 
strong binding constants up to 109 M-1 observed. This macrocyclic host demonstrates good 
generality for a range of analytes as well as high aqueous solubility due to its cationic pendant 
groups, which facilitates its usage in water purification efforts. Moreover, the ability to use cationic 
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exchange resins to remove the cationic pillar[5]arene after binding the analyte, which facilitates 
practical water purification efforts, is also demonstrated, as are comparisons to a neutral 
pillar[5]arene host. Computational efforts are invoked to explain the observed experimental data 
and overall trends. 
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Results and Discussion 
The water-soluble pillar[5]arene host was synthesized with an 80% overall yield over three 
steps. The first step of the synthesis consisted of bromination of para-hydroquinone to form the 
dialkoxyether monomer 1, followed by cyclization using boron trifluoride etherate as a Lewis acid 
to promote the desired cyclization in a solution of 1,2-dichloroethane, which serves as both the bulk 
solvent and as the molecular template for the macrocyclization to form pillar[5]arene 2.  A 
subsequent substitution using N-methylimidazole provided the decacationic pillar[5]arene 3 in an 
81% yield over two steps.37,38  
 
Figure 5.1: Illustration of the synthesis of pillar[5]arene 3 via cyclization of monomer 1 in the 
presence of dichloroethane solvent, followed by nucleophilic substitution of the terminal bromine 
moieties on compound 2.Three-dimensional structures underneath the reaction scheme show 






Molecular mechanics calculations predicted that compound 3 has a unique structure with 
a central cavity (Figure 1), which is readily accessible due to the repulsion created by the ten 
positive charges on the ethylene arms. Pillararene 3’s hydrophobic core, flexible aperture, and 
high water solubility make it a great candidate for binding a wide variety of small organic 
molecules in aqeous media.  Furthermore, the imidazolium cations that are present at the 
termini have the potential to participate in π-π39 or cation-π40 interactions. Consequently, 
we predicted that 3 could accommodate different types of toxicants with a broad variety of 




















Figure 5.2: Array of toxicants and small molecules that were used in the binding study with 
supramolecular host 3, with calculated stabilization energies of the toxicants upon binding in host 
3 (obtained via Spartan 16) shown.The values given represents the stabilization energy for the final 
complex formation between the toxicant and 3. The equation used is  ΔΔH (stabilation energy) =
 ΔH (𝟑 + guest) − ΔH(𝟑) − ΔH(guest). Top - Cartoon image represents the binding phenomena 




Pillararene 3 has a calculated internal diameter of 9 Å and an outer diameter of 11 Å. The diameters 
of toxicants 4-15 in this study ranged from 7 Å to 11.5 Å, which means that most of them should 
be able to fit in the cavity of the supramolecular host. Furthermore, docking studies performed 
using supramolecular host 3 and toxicants 4-15 resulted in calculated stabilization energies and 
docking scores (Table 1) that highlight the favourability of supramolecular complexation.  
As shown in Table 1, the most favourable stabilization energy (largest negative value) 
corresponds to the binding of naproxen (analyte 10), a pharmaceutical drug with some associated 
toxicity, likely as a result of the good complementary fit between the analyte and the 
supramolecular cavity (Figure 3A). This is also true for other molecules such as PFOA (Figure 3B), 
cyclophosphamide (Figure 3C), and 1,10-phenanthroline (Figure 3D), all of which appear to be 
using the majority of the interior space and all of which have key favourable interactions. More 
generally, the uniformly negative stabilization energies obtained for all toxicants in the 
supramolecular host 3 indicate that all complexes should spontaneously form in aqueous media. Of 
note, toxicants such as 1,10-phenanthroline were bound more towards the outer portal of the host 
(Figure 3D), which generally displayed weaker binding compared to binding that was deeper in the 




Figure 5.3: Computed images of analytes docked in macrocycle 3. (A) Naproxen; (B) PFOA; (C) 
Cyclophosphamide; and (D) 1,10-Phenanthroline 
NMR Spectroscopy 
Additionally, 1H NMR spectroscopy investigations provided structural insight into the 
host: guest complex, with shifts observed in the peaks that correspond to the interior protons of 
host 3 and the methylene protons on the imidazolium-terminated side chains (Figure 4). Similarly, 
19F NMR spectroscopy (Figure 5) demonstrated broadening of the fluorine signal that corresponds 
to the PFOA analyte 4 in the presence of the pillararene host, indicating restricted conformational 




Figure 5.4: 1H NMR spectra of: (A) macrocycle 3; and (B) macrocycle 3 and naproxen 10 in a 1:1 
molar ratio. The concentrations of the guest and host were 10 mM each 
 
Figure 5.5: Fluorine NMR spectra of: (A) Perfluorooctanoic acid (PFOA); and (B) complex 




Fluorescence Spectroscopy of Inclusion Complexes 
Fluorescence studies were undertaken to elucidate the binding modes and affinities of the 
small molecule toxicants shown in Figure 2. The results of analyte binding inside cationic 
pillararene 3 are summarized in Table 2, with selected results highlighted in Figures 6 and 7. These 
studies showed that most of the analytes formed 1:1 association complexes both in phosphate 
buffered saline (PBS) as well as in DMSO. The compounds that formed 1:2 complexes in PBS 
included clofibric acid, myclobutanil, and 1,10-phenanthroline, with only 1,10-phenanthroline 
maintaining the 1:2 complex in DMSO as well. Of note, both clofibric acid and myclobutanil 
contain a chlorine-substituted benzene ring with the chlorine in the para-position relative to the rest 
of the structure. Para-chlorobenzene structures have been shown in the literature to bind strongly 
in pillararene structures,41 and the relatively small size of this structure allows for the inclusion of 
two small molecule guests simultaneously.  Simazine formed an unusual 2:1 complex, likely due 
to the ability of the amine substituents to associate with two different pillararene hosts 
simultaneously.  The fact that phenanthroline formed a 1:2 complex is likely due to the ability of 
the heterocyclic aromatic architecture to form strong π-stacked association complexes, in 










Compound number Host:Guest 
Stoichiometry 





Anthracene 1:1 7.18 (0.0001) x 10
5
 N/A 
Carbamazepine 1:1 1.06 (0.12) x 10
5
 N/A 
Clofibric acid 1:2 K
a1









Cyclophosphamide 1:1 1.33 (0.19) x 10
6
 2.17 (0.35) x 10
5
 
Dibutylphtalate 1:1 5.67 (0.97) x 10
5





 = 5.10 (0.92) 
K
a2






1:1 1.62 (0.12) x 10
6
 N/A 
Naproxen 1:1 6.51 (0.911) x 10
3
 N/A 
PFOA 1:1 1.13 (0.13) x 10
6
 2.44 (0.17) x 10
4
 
Phenanthrene 1:1 2.32 (0.02) x 10
4
 8.10 (1.80) x 10
3
 
1,10-Phenothroline 1:2 N/A K
a1







































Figure 5.6: Sample fluorescence titrations of analytes with cationic host 3 used to determine 
binding constants: (A) with simazine guest; and (B) with phenanthrene guest. The black line 
represents the calculated values and the red line represents the experimentally determined values 
 
Figure 5.7: Job’s plot analysis of binding of cationic host 3 with: (A) anthracene and (B) 
phenanthrene small molecule guests 
Interestingly, we synthesized a neutral pillar[5]arene that contains ten propargyl groups as 
a control to compare with the cationic structure of supramolecular host 3. In the control case, most 
of the toxicants formed 1:2 complexes with the propargyl-substituted host, likely as a result of the 
fact that the alkynes extend the size of the hydrophobic cavity and facilitate the binding of multiple 
guest molecules.44 Moreover, cationic host 3 is likely to suffer from charge repulsion, either via 
304 
 
self-repulsion or via repulsion with cationic small molecule guests.1 This charge repulsion, in turn, 
leads to more 1:1 complexation than any other binding stoichiometry.  
Moreover, pillararene 3 showed the strongest binding to simazine in aqueous solution, with 
a 1010 M-1 binding constant observed (for binding the first equivalent of toxicant), and 
myclobutanil, with a 1010 M-1 binding constant observed (for binding a second equivalent of 
toxicant). These binding constants are four orders of magnitude higher than the next highest 
strength constants, seen for clofibric acid, cyclophosphamide, N,N,N’,N’-tetramethylbenzidine, 
perfluorooctanoic acid, and 1,10-phenanthroline, all of which displayed association constants on 
the order of 106 M-1. A structural comparison between the two strongest binding guests indicates 
high levels of electron deficiency for both simazine and myclobutanil. Although other analytes also 
show moderate to significant electron deficiencies, the highly aminated structures of myclobutanil 
and simazine provide additional benefits for association with a cationic supramolecular host, with 
the nitrogen atoms able to associate with the cationic charge. The weakest binding guests, 
phenanthrene (104 M-1) and naproxen (103 M-1), have much higher electron density, which 
disfavours binding inside the pillararene host. 
Switching the solvent to DMSO resulted in decreases in host: guest association complexes, 
with a reduction in binding affinity of up to three orders of magnitude observed (simazine in PBS 
= 1010 M-1; in DMSO = 107 M-1). The decreased binding affinity in non-aqueous environments 
means that the likely mechanism of binding is via hydrophobic association and that switching to 
non-aqueous solvents results in decreasing the energetic favorability of such association. Literature 
precedent strongly supports the notion of hydrophobically-driven binding in pillararene 
architectures, as well as the fact that switching to non-aqueous solvents reduces the favorability of 
hydrophobically-driven inclusion.  
Finally, linear discriminant analysis of the experimentally obtained binding constants 
revealed 100% differentiation between the different toxicants (Figure 8), with clustering between 
structurally similar analytes observed. For example, anthracene, 1,10-phenanthroline and 
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phenanthrene all grouped near each other due to similarities in their planar, polycyclic aromatic 
core. The only fluorinated analyte, PFOA, was found to be separate on the graph from the other 
analytes investigated. Such separation among different analytes, even those with high degrees of 
structural similarity, highlight the potential of this method to enable selective toxicant detection 
capabilities. 
 
Figure 5.8: Linear discriminant analysis of analyte-induced responses upon binding in cationic 
host 3 
Finally, we have shown that pillararene host 3 can be removed by a cation exchange resin 






Figure 5.9: (A) Schematic illustration of removal of toxicant-bound pillararene with cationic 
exchange resin; (B) Quantitative assessment of the amount of 3 that was removed by different 
cation resin types.The black line represents Dowex Marathon resin, the red line represents Dowex 
50WX2 resin, and the blue line represents Amberlite IRN150 resin. (C) Quantitative assessment of 
the amount of naproxen removed after treatment of 3 with resin and (D) Quantitative assessment 
of the amount of phenanthrene removed after treatment of 3 with resin 
As seen on figure 9 we were able to successfully remove naproxen and phenanthrene from an 
aqueous solution using WSP5A as the capture agent and exchange resin as a removal agent, to 





The ability to use rationally designed supramolecular hosts such as pillararene 3 for the 
removal of toxic compounds from contaminated aqueous environments has significant potential 
advantages, provided that the removal can occur with high efficacy for toxic compounds and broad 
relevance for a variety of potential contaminants, and that the contaminants can be removed from 
the aqueous solution following binding. The results reported herein constitute significant progress 
towards achieving this goal, through the development of polycationic pillararene host 3, using 
computational and experimental results to understand its binding to a variety of small molecule 
toxicants, and then demonstrating the practical relevance of such systems via the use of cationic 
exchange resins to remove the complex after toxicant binding. Current efforts in our laboratory are 
focused on the development of practical environmental remediation systems based on such 
technology, and on developing other effective supramolecular systems based on the progress 
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5.2 SUPPORTING INFORMATION 
 
 
Cationic Pillararenes:  Porous Single Molecules for Binding Toxicants in Aqueous Media 
Reagents 
Substrates, including CBr4, dry acetonitrile, dry 1,2-dichloroethane, boron trifluoride etherate, 
triphenylphosphine, methylimidazole were purchased from Sigma-Aldrich, Fisher Scientific, 
and TCI chemicals. All reagents were stored under an inert atmosphere before use. Unless 
otherwise noted, all reactions were performed under N2. 
 
Instrumentation  
NMR spectra were obtained using Bruker Avance 300 MHz and 400 MHz spectrometers. Low-
resolution mass spectrometry was performed using a Shimadzu LRMS-2020.  High-resolution 
mass spectrometry was performed using a Thermo Scientific LTQ Orbitrap XL™ instrument. 
UV-Vis spectra was obtained via Shimadzu UV-Vis spectrophotometer, and Fluorescence 




The synthetic route for the synthesis of Water-soluble pillar[5]arene 
 
 
The above molecule was synthesized according to the literature procedures1, with further 
optimizations and better yields.  
[In the UV-Vis, fluorescence spectra and jobs plot WSP5A is mentioned as PA1 and the neutral 















Synthesis of guest molecules  
  Synthesis of brominated monomer, 1 
 
A solution of 1,4-bis(2-hydroxyethyl)benzene (10.0 g, 50.4 mmol) and triphenylphosphine 
(31.5 g, 120mmol) in dry acetonitrile (250 mL) was cooled in an ice bath. Under vigorous 
stirring, carbon tetrabromide (39.8 g, 120 mmol) was slowly added in four portions. In every 
addition, the solution immediately turns bright yellow and with stirring returns to its colorless 
form. On the final addition, the solution stays cloudy. The mixture was stirred at room 
temperature for 4 hours and 20 minutes. Then cold water (200 mL) was added to the reaction 
mixture to give a white precipitate. The precipitate was collected, washed with another 200 ml 
of cold water followed with methanol/water (3:2, 3 × 100 mL). The collected white solids were 
dried under vacuum for 24 hours and used without further purification. (14.5 g, 97%). 1H NMR 
and 13C NMR was performed using CDCl3. 1H NMR (400 MHz, Chloroform-d) δ 6.89 (s, 4H), 











Figure 5.11: 13C NMR of 1  
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  Synthesis of deca-brominated pillar[5]arene, 2 
 
A solution of brominated monomer (3.37 g, 11.5 mmol) and paraformaldehyde (0.349 g, 11.5 
mmol) in 1,2-dichloroethane (50 mL) was cooled with an ice bath. Boron trifluoride etherate 
(3.26 g, 23.0 mmol) was added to the solution, and the mixture was stirred at room temperature 
for 1 hour. During the 1 hour, the reaction undergoes various color changes. This reaction 
mixture was washed with DI water (2 × 50 mL), saturated sodium bicarbonate (2 x 50 ml) and 
brine solution (2 x 50ml). The organic layer was dried with anhydrous Na2SO4. The solvent 
was evaporated to provide a crude product. The crude product was pure; hence no further 
purification was required. (yield 85%). 1H NMR and 13C NMR were performed using CDCl3. 
1H NMR (400 MHz, Chloroform-d) δ 6.91 (s, 10H), 4.23 (t, J = 6.3, 5.1 Hz, 20H), 3.84 (s, 
















Figure 5.13: 13C NMR of Brominated pillar[5]arene 2  
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Synthesis of deca methyl imidazolium pillar[5]arene, 3 
 
A mixture of brominated pillar[5]arene (1.68 g, 1.00 mmol) and N-methylimidazole (1.64 g, 20.0 
mmol) in toluene (25 mL) was stirred in a 40 mL pressure tube at 120 ºC for 24 hours. The reaction 
was performed multiple times using a round bottom flask, but the reaction never worked. After 
cooling, the solvent was subjected to rotaroy evaporation of the solvent and the residue was then 
dissolved in ethanol and diethylether was added to crash the solid material out of the ethanol 
solution. This white precipitate consisting solution was further cooled for 24 hours and then filtered 
and collected as a off white product. (2.1 g, 87%). 1H NMR and 13C NMR were performed using 
DMSO-d6. 1H NMR (300 MHz, DMSO-d6) δ 9.17 (br, 10H), 8.11 (s, 10H), 7.44 (br, 11H), 6.72 












Figure 5.15: 13C-NMR of 3 
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Mass spectrometry of the water soluble P5A 
 
Figure 5.16: [M − 3Br]3+ Calculated C95H121O10N20Br7 754.1270 
 





Figure 5.18: [M − 6Br]6+ Calculated C95H121O10N20Br4 336.9378 
 
 








Hydroquinone and anhydrous potassium carbonate were added into a solution of 
acetonitrile in RBF. Then the reaction mixture was placed in an ice bath. Next, the 
propargyl bromide was added in dropwise. Then, the reaction solution was stirred 20 hours 
at 60 °C. Once the reaction was completed, the solvent was removed via rotary evaporation. 
Dichloromethane (100 ml) was added into the RBF, and this was transferred into a 
separatory funnel for further washes. Washing steps were conducted using 2.5 M NaOH (3 
x 100 ml) followed with DI water ( 3 x 100 ml) and finally with brine (2 x 100 ml). Then 
the DCM layer was collected and dried over anhydrous sodium sulfate. The final mixture 
was subjected to dry loaded automated flash chromatography. 1H NMR and 13C NMR were 
performed using CDCl3. 1H NMR (400 MHz, DMSO-d6) δ 6.95 (s, 4H), 4.74 (d, J = 2.5 









Figure 5.20: 1H spectrum of proapargylated monomer 
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Proapargylated monomer (3.0 g) and paraformaldehyde (1.45 g) were added into an anhydrous 
solution of DCM. Then FeCl3 was added. The complete reaction mixture was stirred for 3 hours at 
room temperature. Once the 3 hours was over, the reaction was quenched by adding in 200 ml of 
DI water. The organic layer was extracted and washed with 200 ml of brine solution. The collected 
organic layer was dried over anhydrous sodium sulfate and subjected to rotatory evaporation. Next, 
this was packed with silica and dry loaded into automated flash chromatography instrument. The 
final product was light brown.1H NMR and 13C NMR were performed using CDCl3. 1H NMR (400 










Figure 5.21: Flash chromatogram for the purification of Proapargylated P5A, Product was 












Methods for Job’s Plot Experiments 
 
Figure S15 - Job’s plot of anthracene and PA1 in PBS obtained by fluorescence spectroscopy indicating a 1:1 














Table 1 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with anthracene in PBS. γ is mole 




Figure S16 - Fluorescence titration of anthracene with PA1 in PBS fit to a 1:1 anthracene - PA2 stoichiometry. Ka = 
7.18 (0.000076) x 105 M-1; Sum(χ2) = 0.0014. 
 
Figure S17 – Job’s plot of anthracene and PA2 in PBS obtained by fluorescence spectroscopy indicating a 1:2 
anthracene – PA2 binding mode (γmax = 0.37). γ is mole fraction of guest and ΔF is the change in fluorescence 













Table 2 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with anthracene in PBS. γ is mole 
fraction of guest and ΔF is the change in fluorescence integration. 
 
Figure S18– Fluorescence titration of anthracene with PA2 in PBS fit to a 1:2 anthracene - PA2 stoichiometry. Ka1 = 




Figure S19 - Job’s plot analysis of carbamazepine and PA1 in PBS obtained by fluorescence spectroscopy. Indicates a 
likely 1:1 PA1 – carbamazepine binding mode (γmax = 0.55). γ is mole fraction of guest and ΔF is the change in 













Table 3 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with carbamazepine in PBS. γ is 




Figure S20 - Fluorescence titration of PA1 with carbamazepine in PBS fit to a 1:1 stoichiometry. Ka = 1.06(0.12) x 105 
M-1; Sum(χ2) = 0.0017.  
 
Figure S21 – Job’s plot analysis of carbamazepine and PA2 in PBS obtained by fluorescence spectroscopy. Indicates a 
likely 1:2 PA2 – carbamazepine binding mode (γmax = 0.68). γ is mole fraction of guest and ΔF is the change in 















Table 4 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with carbamazepine in PBS. γ is 
mole fraction of guest and ΔF is the change in fluorescence integration. 
 
Figure S22 – Fluorescence titration of PA2 with carbamazepine in PBS fit to a 1:2 stoichiometry. Ka1 = 2.43 




Figure S23 - Job’s plot analysis of clofibric acid and PA1 in PBS obtained by fluorescence spectroscopy. Indicates a 
likely 1:2 PA1 – clofibric acid binding mode (γmax = 0.41). γ is mole fraction of guest and ΔF is the change in 













Table 5 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with clofibric acid in PBS. γ is 




Figure S24 - Fluorescence titration of PA1 with clofibric acid in PBS fit to a 1:2 stoichiometry. Ka1 = 6.34 (1.27) x 106 
M-1; Ka2 = 4.77 (0.32) x 105 M-1; Sum(χ2) = 0.016. 
 
Figure S25 - Job’s plot analysis of cyclophosphamide and PA1 in PBS obtained by fluorescence spectroscopy. 















Table 6 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with cyclophosphamide PBS. γ is 
mole fraction of guest and ΔF is the change in fluorescence integration. 
 
Figure S26 – Fluorescence titration of PA1 with cyclophosphamide in PBS fit to a 1:1 host-guest stoichiometry. Ka = 




Figure S27 - Job’s plot analysis of cyclophosphamide and PA1 in DMSO obtained by fluorescence spectroscopy. 














Table 7 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with cyclophosphamide PBS. γ is 




Figure S28 – Fluorescence titration of PA1 with cyclophosphamide monohydrate in DMSO fit to a 1:1 host-guest 
stoichiometry.  Ka = 2.17 (0.35) x 105 M-1; Sum(χ2) = 0.00113.  
 
Figure S29 - Job’s plot analysis of cyclophosphamide and PA2 in DMSO obtained by fluorescence spectroscopy. 
















Table 8 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with cyclophosphamide in DMSO. 
γ is mole fraction of guest and ΔF is the change in fluorescence integration. 
 
Figure S30 – Fluorescence titration of PA2 with cyclophosphamide in DMSO fit to a 1:1 host-guest stoichiometry. Ka 




Figure S31 – Job’s plot analysis of dibutylphthalate and PA1 in PBS obtained by fluorescence spectroscopy. Indicates 














Table 9 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with dibutylphthalate in PBS. γ is 




Figure S32 - Fluorescence titration of PA1 with dibutylphthalate in PBS fit to a 1:1 host-guest stoichiometry. Ka = 5.67 
(0.95) x 105 M-1; Sum(χ2) = 0.00028. 
 
Figure S33 – Job’s plot analysis of dibutylphthalate and PA1 in DMSO obtained by fluorescence spectroscopy. 
Indicates 1:1 host – guest stoichiometry (γmax = 0.50). γ is mole fraction of guest and ΔF is the change in fluorescence 















Table 10 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with dibutylphthalate in DMSO. 
γ is mole fraction of guest and ΔF is the change in fluorescence integration. 
 
Figure S34 – Fluorescence titration of PA1 with dibutylphthalate in DMSO fit to a 1:1 host-guest stoichiometry. Ka = 





Figure S35 - Job’s plot analysis of dibutylphalate and PA2 in PBS obtained by fluorescence spectroscopy. Indicates a 














Table 11 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with dibutylphthalate in PBS. γ is 




Figure S36 – Fluorescence titration of PA2 with dibutylphthalate in PBS fit to a 1:2 host-guest stoichiometry. Ka1 = 
6.05 (0.0011) x 1010 M-1; Ka2 = 7.14 (2.52) x 104 M-1; Sum(χ2) = 0.0016. 
 
Figure S37 – Job’s plot analysis of dibutylphalate and PA2 in DMSO obtained by fluorescence spectroscopy. Indicates 
















Table 12 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with dibutylphthalate in DMSO. 
γ is mole fraction of guest and ΔF is the change in fluorescence integration. 
 
Figure S38 – Fluorescence titration of PA2 with dibutyl phthalate in DMSO fit to a 1:2 host-guest stoichiometry. Ka1 = 




Figure S39 – Job’s plot analysis of PA1 and myclobutanil in PBS obtained by fluorescence spectroscopy. Indicates a 














Table 13 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with dibutyl phthalate in DMSO. 





Figure S40 – Fluorescence titration of PA1 with myclobutanil in PBS fit to a 1:2 host-guest stoichiometry. Ka1 = 5.10 
(0.92) M-1; Ka2 = 2.62 (0.0044) x 1010 M-1; Sum(χ2) = 0.00045. 
 
Figure S41 – Job’s plot fluorescence analysis of myclobutanil and PA2 in PBS. Indicates no host-guest binding. γ is 















Table 14 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with GUEST in PBS. γ is mole 
fraction of guest and ΔF is the change in fluorescence integration. 
 




Figure S43– Job’s plot titration analysis of N,N,N,N-tetremethylbenzidine and PA1 in PBS obtained by fluorescence 
spectroscopy. Indicates a 1:1 host-guest binding. γ is mole fraction of guest and ΔF is the change in fluorescence 
integration. 












Table 15 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with N,N,N,N-





Figure S44 – Fluorescence titration of N,N,N,N-tetramethylbenzidine with PA1 in PBS fit to a 1:1 host-guest 
stoichiometry. Ka = 1.62 (0.12) x 106 M-1; Sum(χ2) = 0.00023.  
 
Figure S45 - Job’s plot analysis of N,N,N,N-tetramethylbenzidine and PA2 in PBS obtained by fluorescence 
















Table 16 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with N,N,N,N-
tetramethylbenzidine in PBS. γ is mole fraction of guest and ΔF is the change in fluorescence integration. 
 
Figure S46 – Fluorescence titration of N,N,N,N-tetramethylbenzidine with PA2 in PBS fit to a 1:1 host-guest 




Figure S47 – Job’s plot analysis of naproxen and PA1 in PBS obtained by fluorescence spectroscopy indicating a 1:1 
host-guest stoichiometry. γ is mole fraction of guest and ΔF is the change in fluorescence integration. 












Table 17– Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with naproxen in PBS. γ is mole 




Figure S48 – Fluorescence titration of naproxen with PA1 in PBS fit to a 1:1 host-guest stoichiometry. Ka = 6.51 
(0.011) x 103 M-1; Sum(χ2) = 0.00051. 
 
Figure S49 - Job’s plot analysis of naproxen and PA2 in PBS obtained by fluorescence spectroscopy indicating a 1:1 
host-guest stoichiometry (γmax = 0.47). γ is mole fraction of guest and ΔF is the change in fluorescence integration.  
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Table 18 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with naproxen in PBS. γ is mole 
fraction of guest and ΔF is the change in fluorescence integration. 
 
Figure S50 – Job’s plot analysis of perfluorooctanoic acid and PA1 in PBS obtained by fluorescence spectroscopy 
indicating a 1:1 host-guest stoichiometry. γ is mole fraction of guest and ΔF is the change in fluorescence integration. 


















Table 19 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with naproxen in PBS. γ is mole 
fraction of guest and ΔF is the change in fluorescence integration. 
 
Figure S51 – Fluorescence titration of PA1 with PFOA in PBS fit to a 1:1 host-guest stoichiometry. Ka = 1.13 (0.13) x 




Figure S52 – Job’s plot fluorescence analysis of PFOA and PA1 in DMSO. Indicates a 1:1 host-guest stoichiometry 













Table 20 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with PFOA in DMSO. γ is mole 




Figure S53 – Fluorescence titration of PA1 with PFOA in DMSO fit to a 1:1 host-guest stoichiometry. Ka = 2.44 (0.17) 





Figure S54 – NMR titration of PA1 with PFOA in DMSO fit to a 1:1 stoichiometry. Ka = 2.06 (0.0000060) x 102 M-1; 
Sum(χ2) = 0.00000079. 
 
Figure S55 – Job’s plot fluorescence analysis of PFOA and PA2 in DMSO. Indicates a 1:1 host-guest binding 














Table 21 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with PFOA in DMSO. γ is mole 
fraction of guest and ΔF is the change in fluorescence integration. 
 
Figure S56- Fluorescence titration of PA2 with PFOA in DMSO fit to a 1:1 host-guest stoichiometry. Ka = 2.45 (0.21) 




Figure S57 – Job’s plot analysis of phenanthrene and PA1 in PBS, obtained by fluorescence spectroscopy, indicating 













Table 22– Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with phenanthrene in PBS. γ is 




Figure S58 – Fluorescence titration of phenanthrene with PA1 in PBS fit to a 1:1 stoichiometry. Ka = 2.32 (0.020) x 
104 M-1; Sum(χ2) = 0.0016. 
 
Figure S59 – Job’s plot fluorescence analysis of phenanthrene and PA1 in DMSO. Indicates a 1:1 host-guest 















Table 23– Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with phenanthrene in DMSO. γ is 
mole fraction of guest and ΔF is the change in fluorescence integration. 
 
Figure S60 – Fluorescence titration of phenanthrene with PA1 in DMSO fit to a 1:1 stoichiometry. Ka = 8.1 (1.8) x 103 




Figure S61 – Job’s plot fluorescence analysis of phenanthrene and PA2 in PBS. Indicates a 1:1 stoichiometry (γmax = 













Table 24 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with phenanthrene in PBS. γ is 






Figure S62 – Fluorescence titration of phenanthrene and PA2 in PBS fit to a 1:1 stoichiometry. Ka = 1.10 (0.011) x 105 
M-1; Sum(χ2) = 0.0032. 
 
Figure S63 – Job’s plot analysis of phenanthrene and PA2 in DMSO obtained by fluorescence spectroscopy. Indicates 














Table 25 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with phenanthrene in DMSO. γ is 
mole fraction of guest and ΔF is the change in fluorescence integration. 
 
Figure S64 – Fluorescence titration of phenanthrene with PA2 in DMSO fit to a 1:1 stoichiometry. Ka = 5.04 (0.81) x 




Figure S65 - Job’s plot analysis of 1,10-phenanthroline and PA1 in PBS obtained by fluorescence spectroscopy. 
Indicates a 2:1 PA1 – 1,10-phenanthroline stoichiometry (γmax = 0.64).  γ is mole fraction of guest and ΔF is the change 













Table 26 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with 1,10-phenanthroline in PBS. 




Figure S66 - Job’s plot analysis of 1,10-phenanthroline and PA1 in DMSO obtained by fluorescence spectroscopy. 
Indicates a 1:2 1,10-phenanthroline - PA1 stoichiometry (γmax = 0.41).  γ is mole fraction of guest and ΔF is the change 














Table S27 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with 1,10-phenanthroline in 




Figure S67 - Fluorescence titration of 1,10-phenanthroline with PA1 in DMSO fit to a 1:2 1,10-phenanthroline-PA1 
stoichiometry. Ka1 = 4.40 (0.027) x 105 M-1; Ka2 = 2.67 (0.24) x 104 M-1; Sum(χ2) = 0.17. 
 
Figure S68- Job’s plot analysis of 1,10-phenanthroline and PA2 in PBS obtained by fluorescence spectroscopy. 
Indicates a 1:2 1,10-phenanthroline - PA1 stoichiometry (γmax = 0.66).  γ is mole fraction of guest and ΔF is the change 
















Table 28 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with 1,10-phenanthroline in PBS. 
γ is mole fraction of guest and ΔF is the change in fluorescence integration. 
 
Figure S69 - Fluorescence titration of 1,10-phenanthroline with PA2 in PBS; fit to a 1:2 1,10-phenanthroline-PA2 




Figure S70 - Job’s plot analysis of 1,10-phenanthroline and PA2 in DMSO obtained by fluorescence spectroscopy. 
Indicates a 1:2 1,10-phenanthroline - PA1 stoichiometry (γmax = 0.59).  γ is mole fraction of guest and ΔF is the change 











Table S29 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with 1,10-phenanthroline in 




Figure S71 – Fluorescence titration of 1,10-phenanthroline with PA2 in DMSO fit to a 1:2 phenanthroline:PA2 
stoichiometry. Ka1 = 3.08 (0.041) x 102 M-1; Ka2 = 2.89 (0.12) x 107 M-1; Sum(χ2) = 0.066.  
 
Figure S72– Job’s plot fluorescence analysis of simazine and PA1 in PBS. Indicates a 2:1 PA1-simzaine stoichiometry 















Table S30 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with simazine in PBS. γ is mole 
fraction of guest and ΔF is the change in fluorescence integration. 
 
 
Figure S73 – Fluorescence titration of PA1 with dilute simazine in PBS fit to a 2:1 host-guest stoichiometry. Ka1 = 




Figure S74– Job’s plot analysis of simazine and PA1 in DMSO obtained by fluorescence spectroscopy indicating a 1:1 













Table S31– Tabulated data of the Job’s plot analysis of the host-guest binding of PA1 with simazine in DMSO. γ is 




Figure S75 – Fluorescence titration of PA2 with simazine in PBS fit to a 1:2 host-guest stoichiometry. Ka1 = 7.52 
(0.000065) x 1011 M-1; Ka2 = 5.80 (0.42) x 104 M-1; Sum(χ2) = 0.00073.  
 
Figure S76 – Job’s plot fluorescence analysis of simazine and PA2 in DMSO indicating a 1:1 host-guest stoichiometry 















Table S32 – Tabulated data of the Job’s plot analysis of the host-guest binding of PA2 with 




Molecular modeling and stabilization energies 
Two major software packages were used to energy minimize structures, and for docking purposes, 
first one is Spartan16 and the second software is MOE 2018. Spartan was used to perform semi-
empirical level calculations on the complexes, guests and host. These energies obtained after PM3 
calculations were further used for obtaining stabilization energy for complex formation. MOE 
software was used to visualize these structures and to dock specific guests into the cavity of the 
WSP5A using docking tools. For docking receptor was chosen to be the WSp5a, and the ligand 
was chosen to be as the any of the toxicants. Docking parameters were as follows; no wall 
constraints were used to enhance free movement of both ligand and receptor. The docking 
placement method used was “Triangle Matcher,” and the docking score was done using “London 
dG” and “GBVI/WSA dG.” Docking refinement was performed using the “induced fit” method. 
Out of 100 possible confirmations the best 5 were chosen and, and out of the best 5 highest docking 





























Anthracene 242.6439 11053.948 11210.6926 -85.8993 -8.8798 
Phenanthrene 213.8413 11053.948 11235.4887 -32.3006 -8.6756 
1,10-Phenanthroline 
mono hydrate 
770.1826 11053.948 11276.176 -547.9546 -5.4557 
Cyclophosphamide 
mono hydrate 
329.438 11053.948 10563.1687 -820.2173 -10.5119 
Myclobutanil 344.917 11053.948 11295.111 -103.754 -8.5231 
N,N,N,N-
Tetramethylbenzidine 
144.785 11053.948 11131.1368 -67.5962 -9.8271 
Naproxen 476.927 11053.948 10577.8805 -952.9945 -11.4858 
PFOA -
2422.938 
11053.948 7699.1544 -931.8556 -11.8114 
Dibutylpthalate -
758.6346 
11053.948 10247.378 -47.9354 -9.7201 
Carbamazepine 106.135 11053.948 11098.568 -61.515 -8.2642 
Clofibric acid -
486.3014 
11053.948 10487.153 -80.4936 -9.9923 
































































Figure S82. Ligand interaction of Clofibric acid in WSP5A 
 












Figure S83. Docking of Cyclophosphamide acid in WSP5A 






















Figure 85. Docking of Dibutyl phthalate acid in WSP5A 






















Figure S87. Docking of Naproxen in WSP5A 





















Figure S89. Docking of PFOA in WSP5A 





















Figure S91. Docking of Simazine in WSP5A 



































































































Equimolar concentrations (10mM) of WSP5A and Toxicants were prepared in DMSO-d6; the 
reason for using DMSO was used because some of the toxicants are not soluble in water. Then 
these solutions were mixed in a 1:1 ratio in an NMR tube. These were then ultrasonicated for 5 
minutes to enhance complexation. They were allowed out to equilibrate for another 10 minutes. 
Once equilibration was completed all NMR was performed in 400 MHz Bruker NMR spectrometer 






















































Figure S107. 1H- NMR stacked spectra of Naproxen, WSP5A and complex 
405 
 








Figure S108. Stacked 1H NMR of all toxicants in WSp5A with respect to reference WSp5A at 
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Double-stranded DNA-Water soluble P5A based self-aggregate composite material for 
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We prepared water-insoluble self-assembled composite materials by stoichiometric mixing of 
water-soluble decamethylimidazolium pillar[5]arene (WSP5A) with dsDNA obtained from salmon 
milt. The WSP5A has the ability to encapsulate organic molecules into its intramolecular cavity; 
subsequent addition of dsDNA then forms the insoluble network material. By employing this 
strategy, the WSP5A-dsDNA composite material was used for the sequestration and removal of the 





Double-stranded DNS (dsDNA) is a very stable structure and has unique structural 
properties.1 The dsDNA contains a backbone that is consists of phosphate groups which can act as 
a negative charge barrier. In this study, we used dsDNA that is cheap and readily available from 
salmon testes. It was reported in the Hokkaido Bureau of Economy Journal that more than 10,000 
tons/year of milt from salmon trout and others have been removed as industrialized wastes from 
fishery industries in Hokkaido, Japan2 The cost of using milt is low, which enables us to use milt 
as a cost-effective material in this study and to be expanded into practical applications. Also, milt 
is an environmentally friendly biomaterial that has no hazardous effects on the environment after 
use.  
The high anionic charge present salmon milt, due to the phosphate backbone in the DNA 
has been previously used for capturing rare earth elements.2 This dsDNA is stable and can be used 
for several months when its stored at 4 °C. In general applications, salmon testes DNA is used as a 
substrate for deoxyribonuclease assays and other molecular biological techniques.  
 Pillar[5]arenes (P5A) were first discovered by Ogoshi and his group;3 these five-membered 
supramolecular structures are formed via a Lewis acid-mediated Friedls-Crafts reaction between 
formaldehyde and hydroquinone derivatives. In the recent past, this structure has been widely used 
in multiple applications, such as rotaxane synthesis, drug delivery, imaging applications, etc. P5As 
are highly versatile and can be functionalized in various ways. P5A is also used for host-guest 
studies because the hydrophobic cavity can bind small molecules tightly. 
Perfluoroalkylated substances (PFAS) are both environmentally persistent4 and lack 
straightforward detectable methods, which means that the development of methods for their 
removal from contaminated environments is particularly urgent.5 Currently utilized methods for 
PFAS removal include the use of covalent organic frameworks to remove PFAS,6 cyclodextrin 
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polymers for micropollutant (including PFAS) removal,7 chemical oxidation procedures to generate 
highly polar, water-soluble PFAS byproducts,8 and the use of carbon adsorbents to remove PFAS 
from contaminated water,9  Practical drawbacks to these methods include the fact that oxidation 
procedures that generate water-soluble waste products still result in contamination of the water 
supply, and the use of carbon-based absorbents is often non-selective. 
The use of a soluble supramolecular based material for PFAS sequestration and removal 
has not been reported to date, even though such macrocycles could provide maximum flexibility 
by binding PFAS while in solution and could be designed to be removed from solution with ease. 
  
Figure 6.1: Synthesis of dmWSP5A (left), cartoon representation of the dmWSP5A (right) 
This project focused on using the dsDNA as an anchor to hold a host structure. The host structure 
of choice was water soluble methyl imidazolium pillar-5-arene. The methyl dmWSP5A has been 
used for toxicant removal in our previous studies. The concept we wanted to show in this study is 
the use of simple electrostatic interactions in aqueous media to form a self-assembled structure that 
will capture small molecules from water and clump together. This complexed material with the 












Scheme 6-1: Schematic representation of the self-assembled dsDNA-dmWSP5A composite 
material for encapsulation of PFOA 
Experimental section 
Materials. Double-stranded DNA (sodium salt from salmon milt, molecular weight approx. 5 × 
106). Carbon tetrabromide, PFOA, boron trifluoride etherate, and N-methylimidazole were 
purchased from Fisher Scientific. Paraformaldehyde was purchased from Baker Chemicals. All 
solvents and chemicals were purchased from Sigma-Aldrich or Fisher Scientific.  
Decabromopillararene, 1, was synthesized according to literature procedure.16 
Synthesis of decamethylimidazolium pillar[5]arene, A mixture of 1 (1.68 g, 1.00 mmol) and N-
methylimidazole (1.64 g, 20.0 mmol) in toluene (25 mL) was stirred in a 40 mL pressure tube at 
120 ºC for 24 hours.16 (The use of a pressure tube was essential for the success of the reaction in 
our hands.) After cooling, the solvent was removed by rotatory evaporation. The collected residue 
was recrystallized from ethanol/diethyl ether (1:2) to give a white solid (2.1 g, 87%). NMR and 
mass spectra are shown in the attached supplementary information. 
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Preparation of dsDNA-dmWSP5A Composite Material, When an aqueous solution of double-
stranded DNA sodium salt (dsDNA) combined with an aqueous solution of WSP5A, a white, 
gelatanous precipitate formed.  The composite material can be formed using a stoichiometric 1:1 
ratio of dmWSP5A: dsDNA.  This fact is interesting in that similar composite materials require a 
much greater ratio of dsDNA to the host.   
 
Figure 6.2: Stochiometric assay of dsDNA with dmWSP5A. From R to L decreasing WSP5A 
concentration while the dsDNA concentration was held constant 
Accumulation of harmful PFOA This is done by first adding 40 mM WSP5A solution to a 
solution of 20 mM PFOA. The WSP5A rapidly encapsulated the PFOA as it reached equilibrium.  
Next, dsDNA was added to the PFOA/WSP5A mixture, the complex was formed instantly, and it 
could subsequently be removed from the vial.  The resulting supernatant solution was tested for 
PFOA using 19F NMR.  The precipitate was allowed to sit in fresh water to test whether PFOA 






   
 
 
Figure 6.3: Zoomed image of self-assembled composite material in aqueous media (gelatinous) 
Results and Discussion 
The formation of the dsDNA-WSP5A material was obtained by simple mixing of the aqueous 
dsDNA (100 μL, 20 mg/mL) and WSP5A (10-100 μL, 200 mg/mL) solutions. We conducted a 
concentration variation assay, to find the most optimum concentrations for the formation of the 
composite material. Hence, we discovered that at very low concentrations (below 0.1 mM) of 
WSP5A such formation is weak, but after 1:1 or slightly higher concentrations/stoichiometries 
more composite material were observed as seen in Figure 6-2 and 6-3. At very high concentrations 
of WSP5A (500 mM), we did not see any composite material formation; we assume that this is due 
to the lack of enough dsDNA to accommodate the excess WSP5A. The visual observation cue for 
this experiment is the formation of white gel-like material from solution. This gel looks like a “Lava 
lamp” and is a very distinct way of identifying product formation. This gelatinous material is 
insoluble in water and common organic solvents such as dichloromethane, ether, methanol, DMSO 
or NMP.  This gel can be then be stored in ultra-pure water for more than six months without any 
degradation of the structure (Figure 4). All the composite material was made at pH 7, and the 
material was stable at pH 7.  The figure shows the changes in composite material formation going 









Figure 6.4: L to R, Stable self-assembled composite material in ultra-pure water after six months, 
Composite material after drying under vacuum and crushed dried composite material 
Another interesting phenomenon was the dependence of the rate of addition of dsDNA solution 
into the WSP5A solution; the cloudy white material takes on different forms.  If dsDNA is added 
slowly or dropwise, individual strands or drops of the composite material can be formed in the 
solution.  If dsDNA is added quickly, the composite material forms a long string.  Our general 
hypothesis is that electrostatic interactions between the negatively charged phosphate backbone11 
of the dsDNA and the ten positive charges from the methylimidazolium groups on the P5A form 
the composite material. 
Furthermore, the composite material can be removed from the aqueous solution after being formed 
using only tweezers, making it very easy to manipulate and use.  This material can also be dried to 
produce a long rigid string of material that is still brittle enough to be broken.  Its brittleness allows 
one to obtain a powder of the composite material. 
Characterization of dsDNA-dmWSP5A composite material. Though the composite material’s 
ability to precipitate from solution and its insolubility are significant assets to our work, it also 
provides drawbacks in terms of structure determination.  The pseudorandom nature of the dsDNA 
sequence makes crystallography unsuitable.  However, we were able to obtain IR spectroscopy 
measurements and thermogravimetric analysis (TGA). As shown in Figure 6-5, WSP5A (green) 
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has a broad IR signal at 3000 cm-1 which indicates C-H stretching vibrations for WSP5A and the 
broadening significantly shows the vibration of these flexible imidazole containing arms. When 
these imidazoles form a strong interaction with the negatively charged backbone of the double-
stranded DNA the flexibility is converted into a more rigid structure; hence the 3000 cm-1 broad 
signal is no longer seen. Another significant change is shown in the phosphate vibrations; The 1238 
cm-1 peak has moved from left to right going from free DNA to self-assembled complex, which 



















Figure 6.6: Thermogravimetric analysis (TGA) of dsDNA, dmWSP5A and dried composite 
As observed in the TGA study, WSP5A and dsDNA show a sharp decrease in weight, showing that 
the starting materials are pure and un-complexed with other material. The curve for the dried 
composite clearly shows that the decomposition rate has been significantly lowered. This data 
indicates that dsDNA and WSP5A have formed a composite material, presumably via strong 
electrostatic interactions because it requires more time and heat to break these interactions, as 











Figure 6.7: L to R, Protein patch map, the blue is positively charged WSP5A, and red regions are 
for negatively charged phosphate backbone, Ligand interaction diagram of WSP5A to dsDNA 
Figure 6-7 shows that electrostatic interactions play a significant role in bringing the 
dsDNA and the WSP5A together to form a complex. Electrostatic potential maps support our 
prediction by highlighting the positive and negative areas coming together. Also, the ligand 
interaction diagram shows the critical role the positively charged imidazolium ions are playing in 
order to form the complex. Therefore, this rationale can be used to explain the self-aggregated 
structures.  
Accumulation and efficient removal of PFOA from solution and leaching investigations. 
Potential Applications of the Material; DNA is a well-known intercalator for planar molecules13, 
and pillar[n]arenes are known for their ability to encapsulate a guest molecule within their central 
hydrophobic cavity14.  Therefore, combining these two materials into one composite material 
allows for the combination of their properties to encapsulate small molecules.  A natural conclusion 













Figure 6.8: 19F NMR of PFOA capture through the self-assembled composite material 
Perfluorinated compounds have recently been newsworthy because they are harmful byproducts of 
industry suspected to be carcinogens15.  Perfluorooctanoic acid (PFOA) is the guest we chose to 
encapsulate within the complex.  We first investigated the PFOA binding towards the dmWSP5A 
by conducting UV-Vis absorbance studies, which revealed that PFOA binds to the cavity of the 
dmWSP5A with an association constant of 1.13 ± 0.1 x 106 M-1. Also, the binding was a 1:1 
complexation. This was further proven by conducting docking studies followed by molecular 
dynamics computations (Figure 6-8). The experiment was started by first adding 40 mM P5A 
solution to a solution of 20 mM PFOA, and the P5A is allowed to encapsulate the PFOA as it 
reaches equilibrium.  Next, dsDNA is added to the PFOA/P5A mixture, the complex is formed, and 
it can be removed from the vial.  The resulting supernatant solution was tested for PFOA using 19F 
NMR, and no PFOA fluorine peaks were observed in the spectra even after 15,000 scans.  We 
presume the composite material is capturing all the PFOA within its structure.  This Experiment 
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worked even with a stoichiometrically small amount of composite material as compared to PFOA.  
Our experiments ranged from 0.2 equivalents complex to 1.8 equivalents and showed (according 
to 19F NMR) that there was no fluorine within the supernatant solution.  We also tested the idea that 
this composite material could be useful as an environmentally sustainable encapsulation device.  
By using a 1:1 ratio of PFOA to the composite material, we tested the supernatant solution of 
complexes in fresh water over time in order to determine whether PFOA leached out of the 
composite material.  These tests also gave positive results, signaling that no PFOA was found to 
leach from the material throughout over 6 months. In addition, Figure 6-9 clearly shows that there 
is binding of PFOA inside the cavity of the WSP5A, due to when it binds the 19F NMR is showing 
broadening of peaks compared to non-complexed. 
 
Figure 6.9: L to R, hydrophobic pocket present in dmWSP5A, Docked PFOA inside the 
dmWSP5A 
We performed a sub-stoichiometric NMR titration of WSP5A (20 mM) and dsDNA (20 mM) in a 
1:1 ratio to a PFOA (20 mM) solution, with an external standard (1-Fluoro-2,4,6-trimethyl-
pyridinium tetrafluoroborate) in order to quantify the efficiency of the removal. The result of the 
titration clearly shows the encapsulation of the PFOA in WSP5A, and once the dsDNA was added, 
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the broad peak shrunk in size, signaling that the encapsulated PFOA was complexed inside the self-
aggregated dsDNA complex. Also, we can observe that a sharp PFOA peak is seen. This peak 
corresponds to the un-complexed PFOA that is present in the solution. Due to the presence of the 
internal standard, we were able to integrate the area for the PFOA bound, and with that, we can 
conclude that 90% complexed PFOA was removed via the self-aggregation process with the use of 
dsDNA. Furthermore, the final concentration of PFOA in the supernatant solution was found out 
to be 2 mM. Hence, we can assume that with two more cycles of purification that can be taken out 
of the water. 
 
Figure 6.10: 19F NMR of PFOA capture through the self-assembled composite material 
  
PFOA in DI water with 
a few drops of D2O 
After titration of 
dmWSP5A 





The dmWSP5A-dsDNA composite system was used as a successful method to encapsulate and 
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6.2 SUPPORTING INFORMATION 
Double-stranded DNA-Water soluble P5A based self-aggregate composite material for removal of 
PFOA from an aqueous environment 
 
Reagents 
Substrates, including CBr4, dry acetonitrile, dry 1,2-dichloroethane, boron trifluoride ethane, 
triphenyl phosphine, methylimidazole were purchased from Sigma-Aldrich, Fisher Scientific, 
and TCI chemicals. All reagents were stored under an inert atmosphere before use. Unless 
otherwise noted, all reactions were performed under N2. 
 
Instrumentation  
NMR spectra were obtained using Bruker Avance 300 MHz and 400 MHz spectrometers. Low-
resolution mass spectrometry was performed using a Shimadzu LRMS-2020.  High-resolution 
mass spectrometry was performed using a Thermo Scientific LTQ Orbitrap XL™ instrument. 
UV-Vis spectroscopy, Fluorescence spectroscopy 
 





Stoichiometry Experiment  
 
40 mM stock solutions of Pillar[5]arene and DNA from salmon milt were first prepared.  The 
P5A stock solution consisted of dissolving 1.000 g P5A into 10 mL of ultrapure water.  The 
DNA stock solution was determined using the molecular weight per base pair, so 208 mg of 
DNA was dissolved in 10 mL ultrapure water to obtain a 40 mM/b.p. stock solution.  The 
experiment consisted of forming ten complexes separately and then allowing them to rest in 
fresh water for a set period of time.  1 mL of DNA solution was added into each of the 10 vials.  
The ratio of P5A to DNA was varied from 0 to 1.8 eq.  See the chart below for equivalents and 




Mol. DNA Mol. P5A Volume (mL) of 
dmWSP5A  
0 4 x 10-5 0 0 
0.2 8 x 10-6 0.2 
0.4 1.6 x 10-5 0.4 
0.6 2.4 x 10-5 0.6 
0.8 3.2 x 10-5 0.8 
1.0 4.0 x 10-5 1.0 
1.2 4.8 x 10-5 1.2 
   
1.4 5.6 x 10-5 1.4 
1.6 6.4 x 10-5 1.6 
1.8 7.2 x 10-5 1.8 
 
First, the DNA solution was added to the vials.  Then, the corresponding amount of DNA was 
added in order to aggregate the complex spontaneously.  These solutions were allowed to rest 
overnight.  The amount of complex formed was studied and examined in order to determine 






 40 mM stock solutions of Pillar[5]arene and DNA from salmon milt were first prepared.  The 
P5A stock solution consisted of dissolving 1.000 g P5A into 10 mL of ultrapure water.  The 
DNA stock solution was determined using the molecular weight per base pair, so 208 mg of 
DNA was dissolved in 10 mL ultrapure water to obtain a 40 mM/b.p. stock solution.  PFOA 
solutions were prepared at the maximum solubility of PFOA (20 mM) by dissolving 165.6 mg 
PFOA in 20 mL ultrapure water.  The leaching experiment consisted of forming ten complexes 
separately and then allowing them to rest in fresh water for a set period.  2.0 mL PFOA was 
placed into each of the 10 vials.  Then, the ratio of complex to PFOA was varied from 0 to 1.8 




Mol. PFOA Mol. Complex 
(equivalent amounts 
of dmWSP5A and 
dsDNA) 
Volume (mL) of 
dmWSP5A and dsDNA 
solutions added to PFOA 
0 4 x 10-5 0 0/0 
0.2 8 x 10-6 0.2/0.2 
0.4 1.6 x 10-5 0.4/0.4 
0.6 2.4 x 10-5 0.6/0.6 
0.8 3.2 x 10-5 0.8/0.8 
1.0 4.0 x 10-5 1.0/1.0 
1.2 4.8 x 10-5 1.2/1.2 
1.4 5.6 x 10-5 1.4/1.4 
1.6 6.4 x 10-5 1.6/1.6 
1.8 7.2 x 10-5 1.8/1.8 
 
First, the P5A solution was added to the PFOA solutions in order for the PFOA to be encapsulated 
by the P5A.  This mixture was allowed to rest for 10 min.  Then, the corresponding amount of DNA 
was added in order to spontaneously aggregate the complex.  These solutions were allowed to rest 
overnight, and then the excess liquid was analyzed using NMR spectroscopy.  The 1:1 equivalent 
PFOA to the complex was placed in 3 mL fresh D2O and was analyzed using NMR spectroscopy 
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to determine PFOA leaching at 0 h, 1 h, 1 d, 4 d, 7d, and 14 d.  No PFOA leaching was found to 
occur. 
 
Figure 6.11: PFOA bound inside the cavity of the dmWSP5A after multiple iterations using 
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Chloramphenicol is an inhibitor of peptide bond formation by the ribosome and acts by binding to 
the peptidyl transferase active site of the 50S ribosomal subunit. Resistance to chloramphenicol can 
arise from mutations in the 23S rRNA of the ribosome or, more commonly, by inactivation of the 
antibiotic by chloramphenicol acetyltransferase (CAT). Using crystal structures of ribosome-
chloramphenicol and CAT-chloramphenicol complexes as guides, we have synthesized derivatives 
of chloramphenicol rationally modified to impair binding to CAT while still allowing binding to 
ribosomes. While less potent than native chloramphenicol, several derivatives inhibit the growth 
of Bacillus subtilis expressing type III CAT expressed from the resistance determinant pC194. We 
predict that crystal structures of ribosomes bound to modified chloramphenicol will allow more 





Chloramphenicol (CAM) is a bacteriostatic protein synthesis inhibitor effective against both Gram-
positive and Gram-negative bacteria1. It acts as a competitive inhibitor of peptide bond formation 
by binding to the peptidyltransferase active site of the 50S ribosomal subunit, and base substitutions 
in 23S rRNA residues that comprise the drug binding site confer resistance. Early crystal structures 
of chloramphenicol bound to the 50S subunits2 of the bacterium Deinococcus radiodurans and the 
archaeon Haloarcula marismortui3 led to conflicting interpretations of the correct binding mode of 
chloramphenicol. While the H. marismortui structure was at a higher resolution, the D. radiodurans 
structure was more consistent with known chloramphenicol-resistant mutations4. Further, the fact 
that chloramphenicol does not normally inhibit Archaeal protein synthesis added to the confusion. 
This issue was ultimately resolved by crystal structures of chloramphenicol bound to 70S ribosomes 
from the bacteria Escherichia coli5 and Thermus thermophilus. 
Current literature cites various ways CAM has been functionalized, ranging from the attachment 
of amino acids, sugar moieties and bulky groups such as adamantly groups, heterocycles, spermine, 
palmitate, and etc6. Chloramphenicol Acetyltransferase (CAT, EC 2.3.1.28) mono- and di-
acetylates chloramphenicol using acetyl-coenzyme A (Ac-CoA) as the acyl donor, producing 
coenzyme A (CoA-SH) and acetyl-chloramphenicol (Ac-CHL) and di-acetylated chloramphenicol 
(Ac2-CHL) as reaction products. Acetylation presumably sterically hinders interaction with the 
binding site on the ribosome. The crystal structure of type III CAT in complex with 
chloramphenicol has been solved to 1.75 Å resolution. (Leslie, 1990). 
The primary goal of this project was to functionalize CAM in a simple synthetic manner, binding 




MATERIALS AND METHODS 
Synthesis of chloramphenicol derivatives. Chloramphenicol (56-75-7) was purchased from Sigma 
Chemical. Assay for antibiotic sensitivity, Bacillus subtilis 168 and B. subtilis 168 carrying 
plasmid pC194 were obtained from the Bacillus Genetic Stock Center (The Ohio State University) 
and grown in LB medium and plated on Tryptose Blood Agar Base (TBAB). Approximately 108 
cells from a saturated overnight culture were plated onto TBAB. A disc (Whatmann) 
Assay for chloramphenicol acetyltransferase activity, CAT enzyme activity was measured using 
a spectrophotometric assay according to the manufacturer’s instructions (Sigma). This assay is 
based on the transfer of the acetyl group of acetyl-CoA to chloramphenicol, and the subsequent 
reaction of CoA-SH with 5,5'-dithio-bis (2-nitrobenzoic acid; DTNB). Acetyl-CoA, (cat no.), 
DTNB (cat no. D8130) and CAT (cat no. C8413) were purchased from Sigma. 
RESULTS & DISCUSSION 
Rational design of chloramphenicol derivatives. We took advantage of high-resolution co-
crystal structures of ribosome-chloramphenicol (Dunkle et al. 2010; Bulkley et al., 2010) and CAT-
chloramphenicol (Leslie et al. 1988; Leslie 1990) complexes in order to determine the direct contact 
sites between chloramphenicol and these two enzymes. Fortuitously, the interaction of 
chloramphenicol and the two enzymes involve distinct sets of contacts (Figure 1), allowing the 
prediction of sites of modification that would impair recognition by CAT while allowing binding 
to the ribosome.  
As mentioned earlier literature has reported multiple ways to synthesize derivatives of CAM. Our 
group also investigated multiple synthetic procedures. Out of all the procedures, we discovered that 
obtaining CAM base which is the free amine form of the CAM can be obtained with sufficiently 
high yields. The method suggested the use of a 0.1 M NaOH solution in the dark overnight at room 
temperature. We were able to optimize the yields significantly by using 1.46 M NaOH solution. 
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Previous synthesis of CAM base required the use of recrystallization from water. The use of 1.46 
M NaOH instead of the lower concentration helped us to achieve higher yield with approximately 
100% conversion of CAM to CAM-base without the need for recrystallization. The CAM base was 
then subjected to multiple reactions such as peptide coupling, reaction with an acid chloride, etc. 
The most promising derivatives were obtained using isothiocyanates. The reaction between amine 
and iso-thiocyanates or iso-cyanates is known to proceed with high yields and with ease of 
synthesis. This was confirmed by in-silico methods. MOE, molecular operating environment 
computational package was used for this screening process. Out of multiple derivatives, we selected 
a couple of the isothiocyanate derivatives that shows high binding to the 70s ribosome pocket. 
Furthermore, we docked these same derivatives to the pocket of chloramphenicol acetyltransferase 
(CAT), to see if the binding is decreased towards the enzyme. This rationale was used in 
computations, due to the commercially available CAM is known to be inactivated due to the 
binding of CAM to acetyltransferase enzyme, once bound it acetylates the CAM and its anti-biotic 
properties no longer exists. The thiourea derivatives that we synthesize are too large for the pocket 
of the CAM enzyme; hence it does not bind into the enzyme pocket. Binding to the ribosome was 
much higher and we concluded that the thiourea derivatives will still have anti-biotic properties 




















Figure 7.1: Topmost, Complete structure of Thermus thermophilus 70S ribosome in its native 
form, (Bottom left) Active pocket inside the ribosome docked with CAM, (Bottom right) Distances 




















Figure 7.2: Topmost, Complete structure of Chloramphenicol acetyltransferase. (Bottom left) 
Active pocket inside the CAT enzyme docked with CAM (A more open pocket compared to the 





























Figure 7.4: Ligand interaction diagrams for CAM, CAM base and CAM derivative compared with 
ribosome pocket binding (Left side images) and CAM acetyltransferase binding (right side images) 
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As seen in figure 4, compared to CAM and CAM base, the novel thiourea derivative shows more 
interactions with surrounding amino acids present inside the cavity of the ribosome pocket. This is 
due to the introduction of multiple interaction points in the novel derivative such as the thiourea 
moiety along with aromatics and other functional groups these help to form new interactions, which 
in return results in stronger binding to the ribosome pocket. We postulate that due to the tight 
ribosome binding with a high number of interactions, this results in lower or no binding towards 
the incoming CAM acetyltransferase enzyme.  This is further clarified with ligand interaction 
diagrams that are related to the enzyme binding. Comparatively the CAM is bound in the tight 
pocket as seen from the pocket dimensions represented in dashed lines. Hence, in CAM derivative 
the binding is seen in a more open pocket, also there more blue spots which shows the ligand 










Figure 7.5: Flow chart diagram representation of the procedure implemented for the growth 
inhibition zone study in growth media described in methods 
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Growth inhibition of B. subtilis and B. subtilis/pC194 expressing chloramphenicol 
acetyltransferase. We initially tested the inhibitory activity of chloramphenicol derivatives using 
the Gram-positive species B. subtilis 168 due to its sensitivity to this drug, and because of the 
availability of this strain containing the Staphylococcus aureus chloramphenicol-resistance plasmid 






Figure 7.6: Representation of a disk assay and the control disk, the dark area is an indication of no 
growth zone of the bacteria or knows as an inhibition zone 
Chloramphenicol derivatives are poor substrates for acetylation by CAT. CAT enzyme assays 
typically use thin-layer chromatography to detect mono- and di-acetylation of [14C]-
chloramphenicol (Gorman et al. 1982). This assay is not practical for working with semi-synthetic 
chloramphenicol derivatives. Instead, we employed a colorimetric assay (see Materials and 
Methods) based on the detection of deacetylated coenzyme A reaction product by its subsequent 
reaction with DTNB via its free thiol group.  
Effects of derivatives on the growth of Thermus thermophilus chloramphenicol-resistant 
mutants. While less common, resistance to chloramphenicol can be conferred by base substitutions 
in 23S rRNA in the peptidyltransferase active site. We have previously reported a number of such 






base substitutions A2032G, G2061A, A2062G, G2447A, C2452U, A2453G, U2500C, A2503G, 
U2504G, U2504C, U2504A, and G2505A.   
Protein synthesis inhibition of an E. coli extract. One possible explanation for growth inhibition 
by derivatives is the fortuitous generation of an alternative mode of action. The above experiment 














Figure 7.7: Left: B. subtilis 168 (Cam-sensitive); Right: B. subtilis with pC194 (Cam-resistant). 
All new derivatives inhibit Cam-resistant strain 
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The figure 7 shows the inhibition zones with and without the pC194 strain which results in the 
production of CAM acetyltransferase enzyme. This suggests that even with the presence of the 
enzyme all the derivatives show anti-bacterial activity. This data aligns with the data predicted from 
computational docking studies.  
 
Table 7-1: Inhibition zones chart, all the above distances are measured from the end of the disk 
In vitro protein synthesis was carried out using a kit supplied by NEB Labs (PURExpress® In 
Vitro Protein Synthesis Kit) which is a coupled transcription-translation system using E. coli 
ribosomes. The template DNA used was a plasmid containing a T7 polymerase promoter and a 
super folded GFP gene so raw fluorescence could be measured about protein synthesis. Using the 
BioSpectrometer from Eppendorf with the capability to measure fluorescence, an RFU520 value 
was taken every 15 minutes throughout 2 hours. CAM, CAM2, and CAM4 all show inhibition of 






Figure 7.8: In vitro protein synthesis obtained via raw fluorescence units vs. time, excitation at 470 
nm and emission is monitored at 520 nm 
Conclusions 
This study was able to show that eight novel derivatives of CAM has potential anti-bacterial effects 
and does not undergo acylation via the CAT enzyme while retaining their anti-biotic properties. 
Further studies will be conducted to investigate the toxicity of the CAM derivatives and possible 
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7.2 SUPPORTING INFORMATION 




CAM, NaOH, Methanol, diethylether, all the isothiocyantes, dichloromethane 
were purchased from Sigma-Aldrich, Fisher Scientific, and TCI chemicals. All reagents 
were stored under an inert atmosphere before use. Unless otherwise noted, all reactions 
were performed under N2. 
Instrumentation  
NMR spectra were obtained using Bruker Avance 300 MHz and 400 MHz spectrometers. 
Low resolution mass spectrometry was performed using a Shimadzu LRMS-2020. High 
resolution mass spectrometry was performed using a Thermo Scientific LTQ Orbitrap 




Synthesis of CAM base 
 
Chloramphenicol (3g) was charged with 1.46 N NaOH (200 ml) solution, then the RBF was left in 
dark, covered in aluminum foil at room temperature. The reaction time was 18 hours. Then 
extraction was performed as follows, 5 times with diethyl ether (200 ml each), and further 
extractions were performed using ethyl acetate (3 times 200 ml each). Both layers were dried over 
anhydrous sodium sulfate then followed with rotary evaporation. CAM base was obtained as an 
off-white product. This product was used without further purification for the next steps. 1H NMR 
and 13C NMR was performed using DMSO-d6. 1H NMR (400 MHz, DMSO-d6) δ 8.21 – 8.14 (m, 
2H), 7.63 – 7.56 (m, 2H), 5.58 – 5.40 (m, 1H), 4.68 (d, J = 4.3 Hz, 1H), 4.60 (t, J = 5.4 Hz, 1H), 






































Figure 7.10: 1H NMR of CAM base (Hydrolysis of CAM 
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CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were 
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at 
room temperature. Next, the reaction solution was subjected to rotatory evaporation. Then 
it was subjected to flash chromatography. 1H NMR and 13C NMR was performed using 
DMSO-d6. 1H NMR (400 MHz, DMSO-d6) δ 10.36 (s, 1H), 8.32 – 8.28 (m, 2H), 8.22 – 
8.19 (m, 2H), 8.16 – 8.13 (m, 2H), 8.02 (d, J = 8.6 Hz, 1H), 7.92 – 7.87 (m, 2H), 7.68 (d, 
J = 2.3 Hz, 2H), 6.25 (d, J = 4.4 Hz, 1H), 5.25 – 5.16 (m, 1H), 5.11 (br, 1H), 4.60 (qt, J = 
























CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were 
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at 
room temperature. Next, the reaction solution was subjected to rotatory evaporation. Then 
it was subjected to flash chromatography. 1H NMR and 13C NMR was performed using 
DMSO-d6 as a solvent. 1H NMR (400 MHz, DMSO-d6) δ 10.01 (s, 5H), 8.25 – 8.18 (m, 
11H), 7.83 (d, J = 8.6 Hz, 5H), 7.68 – 7.61 (m, 22H), 7.24 (t, J = 1.9 Hz, 5H), 6.22 (d, J = 
4.4 Hz, 5H), 5.23 – 5.16 (m, 5H), 5.05 (dd, J = 6.1, 4.8 Hz, 6H), 4.57 (d, J = 7.6 Hz, 6H), 
























CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were 
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at 
room temperature. Next, the reaction solution was subjected to rotatory evaporation. Then 
it was subjected to flash chromatography. 1H NMR and 13C NMR was performed using 
DMSO-d6 as a solvent. 1H NMR (400 MHz, DMSO-d6) δ 9.94 (s, 1H), 8.24 – 8.19 (m, 
2H), 8.07 (t, J = 1.9 Hz, 1H), 7.74 – 7.70 (m, 1H), 7.69 – 7.60 (m, 4H), 7.42 (t, J = 7.9 Hz, 
1H), 6.22 – 6.11 (m, 1H), 5.20 (d, J = 3.5 Hz, 1H), 5.04 (s, 1H), 4.58 (t, J = 7.5 Hz, 1H), 























CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were 
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at 
room temperature. Next, the reaction solution was subjected to rotatory evaporation. 
Then it was subjected to flash chromatography. 1H NMR and 13C NMR was performed 
using DMSO-d6 as a solvent. 1H NMR (400 MHz, DMSO-d6) δ 10.34 (s, 1H), 8.30 – 8.17 
(m, 4H), 7.95 (d, J = 8.6 Hz, 1H), 7.72 – 7.63 (m, 3H), 6.25 (d, J = 4.4 Hz, 1H), 5.22 (t, J 























CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were 
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at 
room temperature. Next, the reaction solution was subjected to rotatory evaporation. Then 
it was subjected to flash chromatography. 1H NMR and 13C NMR was performed using 
DMSO-d6 as a solvent. 1H NMR (400 MHz, DMSO-d6) δ 9.74 (s, 1H), 8.74 (d, J = 8.7 Hz, 
1H), 8.35 – 8.30 (m, 2H), 8.23 – 8.18 (m, 2H), 8.10 (dd, J = 9.2, 2.7 Hz, 1H), 7.69 – 7.64 
(m, 2H), 6.21 (d, J = 4.3 Hz, 1H), 5.22 (dd, J = 4.5, 2.1 Hz, 1H), 5.08 (dd, J = 6.2, 4.6 Hz, 


















CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were 
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at 
room temperature. Next, the reaction solution was subjected to rotatory evaporation. Then 
it was subjected to flash chromatography. 1H NMR and 13C NMR was performed using 
DMSO-d6 as a solvent. 1H NMR (400 MHz, DMSO-d6) δ 10.02 (s, 1H), 8.26 – 8.16 (m, 
2H), 7.83 (d, J = 8.6 Hz, 1H), 7.69 – 7.60 (m, 4H), 7.24 (t, J = 1.9 Hz, 1H), 6.22 (d, J = 4.4 
Hz, 1H), 5.20 (dd, J = 4.5, 2.0 Hz, 1H), 5.05 (t, J = 5.4 Hz, 1H), 4.63 – 4.51 (m, 1H), 3.54 























CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were 
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at 
room temperature. Next, the reaction solution was subjected to rotatory evaporation. Then 
it was subjected to flash chromatography. 1H NMR and 13C NMR was performed using 
DMSO-d6 as a solvent. 1H NMR (400 MHz, DMSO-d6) δ 9.52 (s, 1H), 8.26 – 8.19 (m, 
2H), 7.65 – 7.55 (m, 2H), 7.44 – 7.35 (m, 3H), 7.24 – 7.15 (m, 2H), 7.04 – 6.95 (m, 3H), 
6.93 – 6.86 (m, 2H), 6.10 (d, J = 4.5 Hz, 1H), 5.16 (s, 1H), 5.00 (dd, J = 6.4, 4.4 Hz, 1H), 


























CAM base was added in with isothiocyanate moiety in 1 : 1.2 equivalents. Both were 
dissolved in anhydrous dichloromethane. The reaction solution was stirred for 12 hours at 
room temperature. Next, the reaction solution was subjected to rotatory evaporation. Then 
it was subjected to flash chromatography. 1H NMR and 13C NMR was performed using 
DMSO-d6 as a solvent. 1H NMR (400 MHz, DMSO-d6) δ 9.60 (s, 1H), 8.25 – 8.20 (m, 
2H), 7.66 – 7.58 (m, 2H), 7.31 (d, J = 8.6 Hz, 1H), 7.04 (ddt, J = 10.5, 1.6, 0.8 Hz, 4H), 
6.96 (s, 2H), 6.74 (dq, J = 1.7, 0.8 Hz, 1H), 6.14 (d, J = 4.5 Hz, 1H), 5.21 – 5.14 (m, 1H), 
5.01 (dd, J = 6.4, 4.4 Hz, 1H), 4.58 (d, J = 6.9 Hz, 1H), 3.57 (dt, J = 9.6, 4.7 Hz, 1H), 3.49 




























Molecular modelling and docking studies 
The PDB structures that was used are 4V7W and 1PD5. Both structures had CAM docked in to 
them in their crystal form. Hence this was a starting point for our calculations. We kept the CAM 
at the same bound site and we changed the functional groups accordingly, then molecular dynamics 
was performed to investigate the most optimum flexible assignment. Once this was obtained the 
CAM derivative was then docked. The docking method used was triangle matcher, with London 
dG scoring system. 100 poses were allowed. Refinement was performed using rigid receptor 
method with a scoring function of GBVI/WSA dG. Next the best 5 poses were refined, and the top 





Figure 7.38: Binding of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-








Figure 7.39: Van der Waals interactions of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3-
dihydroxy-1-(4-nitrophenyl)propan-2-yl)thiourea with the ribosome amino acids 
 
Figure 7.40: Ligand interaction diagram of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3-




Figure 7.41: Binding of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-
nitrophenyl)propan-2-yl)thiourea to the CAM acetyl transferase pocket, with the generated surface 





Figure 7.42: Van der Waals interactions of of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3-
dihydroxy-1-(4-nitrophenyl)propan-2-yl)thiourea with the CAM acetyl transferase  amino acids 
 
Figure 7.43: Ligand interaction diagram of 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-1,3-





Figure 7.44: Binding of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-





Figure 7.45: Van der Waals interactions of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-
yl)-3-(4nitrophenyl)thiourea with the CAM acetyl transferase  amino acids 
 
Figure 7.46: Ligand interaction diagram of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-





Figure 7.47: Binding of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-






Figure 7.48: Van der Waals interactions of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-
yl)-3-(4nitrophenyl)thiourea with the CAM acetyl transferase  amino acids 
 
Figure 7.49: Ligand interaction diagram of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-




Figure 7.50: Binding of 1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-





Figure 7.51: Van der Waals interactions of 1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-
nitrophenyl)propan-2-yl)thiourea with the ribosome amino acids 
 
Figure 7.52: Ligand interaction diagram of 1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-








Figure 7.53: Binding of of 1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-
nitrophenyl)propan-2-yl)thiourea to the CAM acetyl transferase pocket, with the generated surface 





Figure 7.54: Van der Waals interactions of 1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-
nitrophenyl)propan-2-yl)thiourea with the CAM acetyl transferase  amino acids 
 
Figure 7.55: Ligand interaction diagram of 1-(4-chlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-






Figure 7.56: Binding of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(4-





Figure 7.57: Van der Waals interactions of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-
yl)-3-(4-methoxyphenyl)thiourea with the ribosome amino acids 
 
Figure 7.58: Ligand interaction diagram of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-




Figure 7.59: Binding of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(4-





Figure 7.60: Van der Waals interactions of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-
yl)-3-(4-methoxyphenyl)thiourea with the CAM acetyl transferase  amino acids 
 
Figure 7.61: Ligand interaction diagram of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-





Figure 7.62: Binding of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(3,5-





Figure 7.63: Van der Waals interactions of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-
yl)-3-(3,5-dimethylphenyl)thiourea with the ribosome amino acids 
 
Figure 7.64: Ligand interaction diagram of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-






Figure 7.65: Binding of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-3-(3,5-






Figure 7.66: Van der Waals interactions of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-
yl)-3-(3,5-dimethylphenyl)thiourea with the CAM acetyl transferase  amino acids 
 
Figure 7.67: Ligand interaction diagram of 1-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-





Figure 7.68: Binding of 1-(2,5-dihydrofuran-2-yl)-3-((1R,2R)-1,3-dihydroxy-1-(4-






Figure 7.69: Van der Waals interactions of 1-(2,5-dihydrofuran-2-yl)-3-((1R,2R)-1,3-dihydroxy-
1-(4-nitrophenyl)propan-2-yl)thiourea with the ribosome amino acids 
 
Figure 7.70: Ligand interaction diagram of 1-(2,5-dihydrofuran-2-yl)-3-((1R,2R)-1,3-dihydroxy-





Figure 7.71: Binding of 1-(2,5-dihydrofuran-2-yl)-3-((1R,2R)-1,3-dihydroxy-1-(4-
nitrophenyl)propan-2-yl)thiourea to the CAM acetyl transferase pocket, with the generated surface 





Figure 7.72: Van der Waals interactions of 1-(2,5-dihydrofuran-2-yl)-3-((1R,2R)-1,3-dihydroxy-
1-(4-nitrophenyl)propan-2-yl)thiourea with the CAM acetyl transferase  amino acids 
 
Figure 7.73: Ligand interaction diagram of 1-(2,5-dihydrofuran-2-yl)-3-((1R,2R)-1,3-dihydroxy-





Figure 7.74: Binding of 1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-






Figure 7.75: Van der Waals interactions of 1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-
(4-nitrophenyl)propan-2-yl)thiourea with the ribosome amino acids 
 
Figure 7.76: Ligand interaction diagram of 1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-




Figure 7.77: Binding of 1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-
nitrophenyl)propan-2-yl)thiourea to the CAM acetyl transferase pocket, with the generated surface 





Figure 7.78: Van der Waals interactions of 1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-
(4-nitrophenyl)propan-2-yl)thiourea with the CAM acetyl transferase  amino acids 
 
Figure 7.79: Ligand interaction diagram of 1-(3,5-dichlorophenyl)-3-((1R,2R)-1,3-dihydroxy-1-








Figure 7.80: Binding of 1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-





Figure 7.81: Van der Waals interactions of 1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-
nitrophenyl)propan-2-yl)thiourea with the ribosome amino acids 
 
Figure 7.82: Van der Waals interactions of 1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-




Figure 7.83: Binding of 1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-





Figure 7.84: Binding of 1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-
yl)thiourea to the CAM acetyl transferase pocket, with the generated surface for the receptor 
 
Figure 7.85: Ligand interaction diagram of 1-(4-acetylphenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-






Figure 7.86: Binding of 1-(2-chloro-4-nitrophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-






Figure 7.87: Ligand interaction diagram of 1-(2-chloro-4-nitrophenyl)-3-((1R,2R)-1,3-dihydroxy-





Figure 7.88: Binding of 1-(2-chloro-4-nitrophenyl)-3-((1R,2R)-1,3-dihydroxy-1-(4-
nitrophenyl)propan-2-yl)thiourea to the CAM acetyl transferase pocket, with the generated surface 





Figure 7.89: Ligand interaction diagram of 1-(2-chloro-4-nitrophenyl)-3-((1R,2R)-1,3-dihydroxy-







                                                     
